Information Center
Your Health. Your Family. Your Choice.
|
|
National Vaccine Information Center Your Health. Your Family. Your Choice. |
MedAlerts Home |
| Table |
 |   | |
| Symptoms | Count | Percent |
| Abdomen scan | 2 | 0.03% |
| Abdomen scan normal | 3 | 0.05% |
| Abdominal discomfort | 55 | 0.86% |
| Abdominal distension | 33 | 0.52% |
| Abdominal mass | 2 | 0.03% |
| Abdominal pain | 203 | 3.18% |
| Abdominal pain lower | 24 | 0.38% |
| Abdominal pain upper | 158 | 2.48% |
| Abdominal rigidity | 3 | 0.05% |
| Abdominal tenderness | 9 | 0.14% |
| Abdominal X-ray | 8 | 0.13% |
| Abnormal behaviour | 9 | 0.14% |
| Abnormal clotting factor | 1 | 0.02% |
| Abnormal dreams | 3 | 0.05% |
| Abnormal faeces | 2 | 0.03% |
| Abnormal loss of weight | 3 | 0.05% |
| Abnormal sensation in eye | 1 | 0.02% |
| Abortion induced | 1 | 0.02% |
| Abortion spontaneous | 13 | 0.2% |
| Abscess | 2 | 0.03% |
| Abscess drainage | 1 | 0.02% |
| Abscess limb | 1 | 0.02% |
| Accidental overdose | 2 | 0.03% |
| Acid base balance | 1 | 0.02% |
| Acidosis | 1 | 0.02% |
| Acne | 3 | 0.05% |
| Acoustic stimulation tests | 4 | 0.06% |
| Acoustic stimulation tests abnormal | 2 | 0.03% |
| Acoustic stimulation tests normal | 4 | 0.06% |
| Acquired diaphragmatic eventration | 1 | 0.02% |
| Activated partial thromboplastin time | 27 | 0.42% |
| Activated partial thromboplastin time normal | 8 | 0.13% |
| Activated partial thromboplastin time prolonged | 2 | 0.03% |
| Activated partial thromboplastin time shortened | 15 | 0.24% |
| Activated protein C resistance test | 1 | 0.02% |
| Acupuncture | 1 | 0.02% |
| Acute coronary syndrome | 2 | 0.03% |
| Acute disseminated encephalomyelitis | 1 | 0.02% |
| Acute kidney injury | 19 | 0.3% |
| Acute myocardial infarction | 16 | 0.25% |
| Acute pulmonary oedema | 1 | 0.02% |
| Acute respiratory distress syndrome | 3 | 0.05% |
| Acute respiratory failure | 10 | 0.16% |
| ADAMTS13 activity abnormal | 1 | 0.02% |
| ADAMTS13 activity assay | 1 | 0.02% |
| ADAMTS13 activity normal | 1 | 0.02% |
| Adenovirus test | 1 | 0.02% |
| Administration site pain | 1 | 0.02% |
| Adnexa uteri pain | 1 | 0.02% |
| Adrenal disorder | 1 | 0.02% |
| Adrenal haemorrhage | 2 | 0.03% |
| Adrenocortical insufficiency acute | 2 | 0.03% |
| Adverse drug reaction | 3 | 0.05% |
| Adverse event | 11 | 0.17% |
| Adverse food reaction | 1 | 0.02% |
| Adverse reaction | 12 | 0.19% |
| Affect lability | 1 | 0.02% |
| Ageusia | 34 | 0.53% |
| Aggression | 3 | 0.05% |
| Agitation | 7 | 0.11% |
| Agonal rhythm | 1 | 0.02% |
| Airway secretion clearance therapy | 1 | 0.02% |
| Alanine aminotransferase | 3 | 0.05% |
| Alanine aminotransferase increased | 15 | 0.24% |
| Alanine aminotransferase normal | 21 | 0.33% |
| Albumin globulin ratio | 8 | 0.13% |
| Albumin globulin ratio decreased | 1 | 0.02% |
| Albumin globulin ratio increased | 1 | 0.02% |
| Albumin globulin ratio normal | 4 | 0.06% |
| Albumin urine | 2 | 0.03% |
| Alcohol test | 1 | 0.02% |
| Alcohol test negative | 2 | 0.03% |
| Alcohol use | 1 | 0.02% |
| Allergy test | 2 | 0.03% |
| Allergy test negative | 1 | 0.02% |
| Allergy to vaccine | 7 | 0.11% |
| Allodynia | 3 | 0.05% |
| Alopecia | 5 | 0.08% |
| Altered state of consciousness | 4 | 0.06% |
| Altered visual depth perception | 3 | 0.05% |
| Alveolar-arterial oxygen gradient | 1 | 0.02% |
| Alveolitis | 1 | 0.02% |
| Amenorrhoea | 1 | 0.02% |
| Ammonia | 1 | 0.02% |
| Ammonia normal | 1 | 0.02% |
| Amnesia | 32 | 0.5% |
| Amylase | 4 | 0.06% |
| Amylase decreased | 1 | 0.02% |
| Amylase normal | 1 | 0.02% |
| Anaemia | 9 | 0.14% |
| Anaesthesia oral | 2 | 0.03% |
| Analgesic drug level | 1 | 0.02% |
| Anal incontinence | 11 | 0.17% |
| Anaphylactic reaction | 45 | 0.71% |
| Anaphylactic shock | 11 | 0.17% |
| Anaphylactoid reaction | 1 | 0.02% |
| Androgenetic alopecia | 1 | 0.02% |
| Aneurysm | 1 | 0.02% |
| Aneurysm ruptured | 1 | 0.02% |
| Anger | 2 | 0.03% |
| Anginal equivalent | 1 | 0.02% |
| Angina pectoris | 16 | 0.25% |
| Angina unstable | 1 | 0.02% |
| Angiocardiogram | 2 | 0.03% |
| Angioedema | 13 | 0.2% |
| Angiogram | 69 | 1.08% |
| Angiogram abnormal | 9 | 0.14% |
| Angiogram cerebral | 5 | 0.08% |
| Angiogram cerebral abnormal | 31 | 0.49% |
| Angiogram cerebral normal | 16 | 0.25% |
| Angiogram normal | 10 | 0.16% |
| Angiogram peripheral | 1 | 0.02% |
| Angiogram peripheral abnormal | 1 | 0.02% |
| Angiogram pulmonary | 6 | 0.09% |
| Angiogram pulmonary abnormal | 57 | 0.89% |
| Angiogram pulmonary normal | 7 | 0.11% |
| Angiopathy | 1 | 0.02% |
| Angioplasty | 1 | 0.02% |
| Angiotensin converting enzyme | 3 | 0.05% |
| Anhedonia | 1 | 0.02% |
| Animal bite | 1 | 0.02% |
| Anion gap | 12 | 0.19% |
| Anion gap decreased | 4 | 0.06% |
| Anion gap normal | 6 | 0.09% |
| Anisocytosis | 1 | 0.02% |
| Ankle brachial index | 1 | 0.02% |
| Ankle brachial index normal | 1 | 0.02% |
| Ankle fracture | 1 | 0.02% |
| Anosmia | 23 | 0.36% |
| Anti-ganglioside antibody | 1 | 0.02% |
| Anti-glomerular basement membrane disease | 1 | 0.02% |
| Anti-muscle specific kinase antibody negative | 1 | 0.02% |
| Anti-myelin-associated glycoprotein antibodies positive | 1 | 0.02% |
| Anti-platelet antibody | 1 | 0.02% |
| Anti-RNA polymerase III antibody | 1 | 0.02% |
| Anti-thyroid antibody | 2 | 0.03% |
| Anti-transglutaminase antibody | 1 | 0.02% |
| Antiacetylcholine receptor antibody | 2 | 0.03% |
| Antibody test | 7 | 0.11% |
| Antibody test negative | 1 | 0.02% |
| Antibody test normal | 2 | 0.03% |
| Anticoagulant therapy | 105 | 1.65% |
| Anticoagulation drug level | 1 | 0.02% |
| Anti factor VIII antibody test | 1 | 0.02% |
| Anti factor Xa assay normal | 1 | 0.02% |
| Antineutrophil cytoplasmic antibody | 1 | 0.02% |
| Antineutrophil cytoplasmic antibody negative | 2 | 0.03% |
| Antinuclear antibody | 7 | 0.11% |
| Antinuclear antibody negative | 4 | 0.06% |
| Antinuclear antibody positive | 7 | 0.11% |
| Antiphospholipid antibodies | 4 | 0.06% |
| Antiphospholipid antibodies negative | 2 | 0.03% |
| Antipsychotic drug level | 1 | 0.02% |
| Antithrombin III | 2 | 0.03% |
| Antithrombin III decreased | 2 | 0.03% |
| Anuria | 1 | 0.02% |
| Anxiety | 154 | 2.41% |
| Aortic aneurysm | 1 | 0.02% |
| Aortic dilatation | 1 | 0.02% |
| Aortic dissection | 1 | 0.02% |
| Aortic occlusion | 2 | 0.03% |
| Aortic thrombosis | 1 | 0.02% |
| Aortic valve incompetence | 4 | 0.06% |
| Aortic valve replacement | 1 | 0.02% |
| Apallic syndrome | 1 | 0.02% |
| Apathy | 2 | 0.03% |
| Aphasia | 63 | 0.99% |
| Aphonia | 5 | 0.08% |
| Aphthous ulcer | 4 | 0.06% |
| Aplastic anaemia | 1 | 0.02% |
| Apnoea | 1 | 0.02% |
| Apnoeic attack | 1 | 0.02% |
| Appendicectomy | 19 | 0.3% |
| Appendicitis | 20 | 0.31% |
| Appendicitis perforated | 4 | 0.06% |
| Appetite disorder | 1 | 0.02% |
| Application site rash | 1 | 0.02% |
| Areflexia | 2 | 0.03% |
| Arrhythmia | 17 | 0.27% |
| Arterial occlusive disease | 5 | 0.08% |
| Arterial rupture | 1 | 0.02% |
| Arterial stenosis | 1 | 0.02% |
| Arterial thrombosis | 2 | 0.03% |
| Arteriogram | 1 | 0.02% |
| Arteriogram carotid | 11 | 0.17% |
| Arteriogram carotid abnormal | 10 | 0.16% |
| Arteriogram carotid normal | 11 | 0.17% |
| Arteriogram coronary abnormal | 3 | 0.05% |
| Arteriogram coronary normal | 3 | 0.05% |
| Arteriosclerosis | 1 | 0.02% |
| Arteriosclerosis coronary artery | 2 | 0.03% |
| Arteriosclerotic retinopathy | 1 | 0.02% |
| Arteriospasm coronary | 2 | 0.03% |
| Arteritis | 1 | 0.02% |
| Arthralgia | 294 | 4.61% |
| Arthritis | 9 | 0.14% |
| Arthropod bite | 4 | 0.06% |
| Arthroscopy | 1 | 0.02% |
| Aspartate aminotransferase | 3 | 0.05% |
| Aspartate aminotransferase decreased | 4 | 0.06% |
| Aspartate aminotransferase increased | 14 | 0.22% |
| Aspartate aminotransferase normal | 20 | 0.31% |
| Asphyxia | 2 | 0.03% |
| Aspiration | 2 | 0.03% |
| Aspiration pleural cavity | 1 | 0.02% |
| Asthenia | 362 | 5.67% |
| Asthenopia | 6 | 0.09% |
| Asthma | 31 | 0.49% |
| AST to platelet ratio index increased | 1 | 0.02% |
| Asymptomatic COVID-19 | 3 | 0.05% |
| Ataxia | 5 | 0.08% |
| Atelectasis | 17 | 0.27% |
| Atrial enlargement | 2 | 0.03% |
| Atrial fibrillation | 55 | 0.86% |
| Atrial flutter | 6 | 0.09% |
| Atrial septal defect | 5 | 0.08% |
| Atrioventricular block | 3 | 0.05% |
| Atrioventricular block complete | 1 | 0.02% |
| Atrophy | 1 | 0.02% |
| Atrophy of globe | 1 | 0.02% |
| Atypical pneumonia | 1 | 0.02% |
| Audiogram | 2 | 0.03% |
| Audiogram abnormal | 2 | 0.03% |
| Auditory disorder | 1 | 0.02% |
| Aura | 5 | 0.08% |
| Autoimmune demyelinating disease | 1 | 0.02% |
| Autoimmune disorder | 7 | 0.11% |
| Autoimmune hepatitis | 1 | 0.02% |
| Autoimmune myocarditis | 1 | 0.02% |
| Autoimmune thyroiditis | 1 | 0.02% |
| Automatic positive airway pressure | 1 | 0.02% |
| Autonomic nervous system imbalance | 3 | 0.05% |
| Autopsy | 4 | 0.06% |
| Autoscopy | 1 | 0.02% |
| Axillary nerve injury | 1 | 0.02% |
| Axillary pain | 15 | 0.24% |
| Axillary vein thrombosis | 2 | 0.03% |
| B-cell lymphoma | 1 | 0.02% |
| Back disorder | 2 | 0.03% |
| Back injury | 2 | 0.03% |
| Back pain | 225 | 3.53% |
| Bacterial infection | 3 | 0.05% |
| Bacterial test | 3 | 0.05% |
| Bacterial test negative | 4 | 0.06% |
| Bacterial test positive | 4 | 0.06% |
| Balance disorder | 86 | 1.35% |
| Band neutrophil percentage increased | 1 | 0.02% |
| Barium swallow | 1 | 0.02% |
| Basal ganglia haemorrhage | 1 | 0.02% |
| Basal ganglia infarction | 2 | 0.03% |
| Basedow's disease | 1 | 0.02% |
| Basilar artery occlusion | 1 | 0.02% |
| Basophil count decreased | 12 | 0.19% |
| Basophil count normal | 8 | 0.13% |
| Basophil percentage | 12 | 0.19% |
| Basophil percentage decreased | 4 | 0.06% |
| Basophil percentage increased | 2 | 0.03% |
| Bed rest | 3 | 0.05% |
| Bedridden | 4 | 0.06% |
| Behaviour disorder | 4 | 0.06% |
| Bell's palsy | 105 | 1.65% |
| Beta-2 glycoprotein antibody | 1 | 0.02% |
| Beta-2 glycoprotein antibody negative | 1 | 0.02% |
| Beta 2 microglobulin normal | 1 | 0.02% |
| Beta haemolytic streptococcal infection | 2 | 0.03% |
| Bicytopenia | 1 | 0.02% |
| Bile duct stent insertion | 1 | 0.02% |
| Bile duct stone | 1 | 0.02% |
| Bilevel positive airway pressure | 7 | 0.11% |
| Biliary colic | 1 | 0.02% |
| Biliary dilatation | 1 | 0.02% |
| Biliary obstruction | 1 | 0.02% |
| Bilirubin conjugated normal | 1 | 0.02% |
| Bilirubin urine | 7 | 0.11% |
| Biopsy | 10 | 0.16% |
| Biopsy abdominal wall normal | 1 | 0.02% |
| Biopsy artery | 2 | 0.03% |
| Biopsy blood vessel | 1 | 0.02% |
| Biopsy blood vessel abnormal | 1 | 0.02% |
| Biopsy bone marrow | 3 | 0.05% |
| Biopsy bone marrow normal | 1 | 0.02% |
| Biopsy brain | 1 | 0.02% |
| Biopsy colon abnormal | 1 | 0.02% |
| Biopsy heart | 2 | 0.03% |
| Biopsy liver | 2 | 0.03% |
| Biopsy lung | 2 | 0.03% |
| Biopsy muscle abnormal | 2 | 0.03% |
| Biopsy skin | 5 | 0.08% |
| Biopsy skin abnormal | 1 | 0.02% |
| Biopsy soft tissue | 1 | 0.02% |
| Biopsy stomach normal | 1 | 0.02% |
| Bipolar disorder | 1 | 0.02% |
| Bladder catheterisation | 3 | 0.05% |
| Bladder scan | 1 | 0.02% |
| Blepharospasm | 11 | 0.17% |
| Blindness | 30 | 0.47% |
| Blindness transient | 6 | 0.09% |
| Blindness unilateral | 18 | 0.28% |
| Blister | 29 | 0.45% |
| Blister rupture | 1 | 0.02% |
| Blood 25-hydroxycholecalciferol | 2 | 0.03% |
| Blood albumin decreased | 12 | 0.19% |
| Blood albumin increased | 1 | 0.02% |
| Blood albumin normal | 16 | 0.25% |
| Blood alcohol normal | 1 | 0.02% |
| Blood alkaline phosphatase | 2 | 0.03% |
| Blood alkaline phosphatase increased | 8 | 0.13% |
| Blood alkaline phosphatase normal | 20 | 0.31% |
| Blood beta-D-glucan | 1 | 0.02% |
| Blood bicarbonate abnormal | 1 | 0.02% |
| Blood bicarbonate decreased | 2 | 0.03% |
| Blood bicarbonate increased | 1 | 0.02% |
| Blood bicarbonate normal | 4 | 0.06% |
| Blood bilirubin | 4 | 0.06% |
| Blood bilirubin decreased | 1 | 0.02% |
| Blood bilirubin increased | 7 | 0.11% |
| Blood bilirubin normal | 21 | 0.33% |
| Blood blister | 2 | 0.03% |
| Blood calcitonin normal | 1 | 0.02% |
| Blood calcium | 2 | 0.03% |
| Blood calcium decreased | 15 | 0.24% |
| Blood calcium increased | 3 | 0.05% |
| Blood calcium normal | 12 | 0.19% |
| Blood cannabinoids | 1 | 0.02% |
| Blood chloride | 2 | 0.03% |
| Blood chloride decreased | 3 | 0.05% |
| Blood chloride increased | 10 | 0.16% |
| Blood chloride normal | 19 | 0.3% |
| Blood cholesterol | 2 | 0.03% |
| Blood cholesterol increased | 5 | 0.08% |
| Blood cholesterol normal | 5 | 0.08% |
| Blood cholinesterase normal | 1 | 0.02% |
| Blood copper | 1 | 0.02% |
| Blood copper increased | 1 | 0.02% |
| Blood count | 4 | 0.06% |
| Blood count normal | 1 | 0.02% |
| Blood creatine | 3 | 0.05% |
| Blood creatine normal | 1 | 0.02% |
| Blood creatine phosphokinase | 12 | 0.19% |
| Blood creatine phosphokinase decreased | 2 | 0.03% |
| Blood creatine phosphokinase increased | 14 | 0.22% |
| Blood creatine phosphokinase MB | 2 | 0.03% |
| Blood creatine phosphokinase MB increased | 2 | 0.03% |
| Blood creatine phosphokinase MB normal | 2 | 0.03% |
| Blood creatine phosphokinase normal | 13 | 0.2% |
| Blood creatinine | 8 | 0.13% |
| Blood creatinine decreased | 2 | 0.03% |
| Blood creatinine increased | 21 | 0.33% |
| Blood creatinine normal | 33 | 0.52% |
| Blood culture | 20 | 0.31% |
| Blood culture negative | 12 | 0.19% |
| Blood disorder | 2 | 0.03% |
| Blood electrolytes | 5 | 0.08% |
| Blood electrolytes decreased | 1 | 0.02% |
| Blood electrolytes normal | 8 | 0.13% |
| Blood ethanol | 1 | 0.02% |
| Blood fibrinogen | 7 | 0.11% |
| Blood fibrinogen abnormal | 1 | 0.02% |
| Blood fibrinogen decreased | 3 | 0.05% |
| Blood fibrinogen increased | 4 | 0.06% |
| Blood fibrinogen normal | 3 | 0.05% |
| Blood folate | 2 | 0.03% |
| Blood folate increased | 1 | 0.02% |
| Blood folate normal | 6 | 0.09% |
| Blood follicle stimulating hormone | 2 | 0.03% |
| Blood follicle stimulating hormone normal | 1 | 0.02% |
| Blood gases | 8 | 0.13% |
| Blood gases normal | 1 | 0.02% |
| Blood glucose | 48 | 0.75% |
| Blood glucose abnormal | 6 | 0.09% |
| Blood glucose decreased | 12 | 0.19% |
| Blood glucose increased | 34 | 0.53% |
| Blood glucose normal | 64 | 1% |
| Blood grouping | 1 | 0.02% |
| Blood homocysteine | 1 | 0.02% |
| Blood immunoglobulin E | 1 | 0.02% |
| Blood immunoglobulin E normal | 1 | 0.02% |
| Blood immunoglobulin G | 2 | 0.03% |
| Blood immunoglobulin G normal | 2 | 0.03% |
| Blood iron | 1 | 0.02% |
| Blood iron decreased | 5 | 0.08% |
| Blood ketone body | 1 | 0.02% |
| Blood lactate dehydrogenase | 5 | 0.08% |
| Blood lactate dehydrogenase increased | 4 | 0.06% |
| Blood lactate dehydrogenase normal | 2 | 0.03% |
| Blood lactic acid | 29 | 0.45% |
| Blood lactic acid decreased | 2 | 0.03% |
| Blood lactic acid increased | 7 | 0.11% |
| Blood lactic acid normal | 5 | 0.08% |
| Blood luteinising hormone | 1 | 0.02% |
| Blood magnesium | 31 | 0.49% |
| Blood magnesium decreased | 3 | 0.05% |
| Blood magnesium increased | 2 | 0.03% |
| Blood magnesium normal | 21 | 0.33% |
| Blood osmolarity | 1 | 0.02% |
| Blood osmolarity decreased | 3 | 0.05% |
| Blood osmolarity normal | 1 | 0.02% |
| Blood pH | 2 | 0.03% |
| Blood pH decreased | 2 | 0.03% |
| Blood pH increased | 2 | 0.03% |
| Blood pH normal | 1 | 0.02% |
| Blood phosphorus | 9 | 0.14% |
| Blood phosphorus increased | 1 | 0.02% |
| Blood phosphorus normal | 1 | 0.02% |
| Blood potassium | 6 | 0.09% |
| Blood potassium decreased | 31 | 0.49% |
| Blood potassium increased | 6 | 0.09% |
| Blood potassium normal | 29 | 0.45% |
| Blood pressure abnormal | 6 | 0.09% |
| Blood pressure decreased | 36 | 0.56% |
| Blood pressure diastolic | 2 | 0.03% |
| Blood pressure diastolic increased | 2 | 0.03% |
| Blood pressure fluctuation | 7 | 0.11% |
| Blood pressure immeasurable | 1 | 0.02% |
| Blood pressure increased | 162 | 2.54% |
| Blood pressure measurement | 100 | 1.57% |
| Blood pressure normal | 7 | 0.11% |
| Blood pressure systolic | 2 | 0.03% |
| Blood pressure systolic normal | 1 | 0.02% |
| Blood smear test | 1 | 0.02% |
| Blood smear test normal | 2 | 0.03% |
| Blood sodium | 5 | 0.08% |
| Blood sodium decreased | 16 | 0.25% |
| Blood sodium increased | 1 | 0.02% |
| Blood sodium normal | 27 | 0.42% |
| Blood test | 711 | 11.14% |
| Blood test abnormal | 50 | 0.78% |
| Blood test normal | 194 | 3.04% |
| Blood thyroid stimulating hormone | 36 | 0.56% |
| Blood thyroid stimulating hormone abnormal | 1 | 0.02% |
| Blood thyroid stimulating hormone decreased | 3 | 0.05% |
| Blood thyroid stimulating hormone increased | 2 | 0.03% |
| Blood thyroid stimulating hormone normal | 15 | 0.24% |
| Blood triglycerides | 3 | 0.05% |
| Blood triglycerides increased | 1 | 0.02% |
| Blood triglycerides normal | 3 | 0.05% |
| Blood urea | 4 | 0.06% |
| Blood urea decreased | 7 | 0.11% |
| Blood urea increased | 11 | 0.17% |
| Blood urea nitrogen/creatinine ratio | 6 | 0.09% |
| Blood urea normal | 25 | 0.39% |
| Blood urine | 3 | 0.05% |
| Blood urine absent | 4 | 0.06% |
| Blood urine present | 25 | 0.39% |
| Bloody discharge | 1 | 0.02% |
| Blue toe syndrome | 1 | 0.02% |
| Body mass index | 3 | 0.05% |
| Body temperature | 82 | 1.28% |
| Body temperature decreased | 13 | 0.2% |
| Body temperature fluctuation | 1 | 0.02% |
| Body temperature increased | 45 | 0.71% |
| Body temperature normal | 2 | 0.03% |
| Bone densitometry | 1 | 0.02% |
| Bone lesion | 1 | 0.02% |
| Bone pain | 14 | 0.22% |
| Bone scan | 1 | 0.02% |
| Borrelia test | 8 | 0.13% |
| Borrelia test negative | 4 | 0.06% |
| Borrelia test positive | 2 | 0.03% |
| Bowel movement irregularity | 1 | 0.02% |
| Bradycardia | 13 | 0.2% |
| Bradykinesia | 5 | 0.08% |
| Bradyphrenia | 3 | 0.05% |
| Brain compression | 1 | 0.02% |
| Brain death | 2 | 0.03% |
| Brain herniation | 2 | 0.03% |
| Brain injury | 5 | 0.08% |
| Brain natriuretic peptide | 18 | 0.28% |
| Brain natriuretic peptide increased | 11 | 0.17% |
| Brain natriuretic peptide normal | 7 | 0.11% |
| Brain oedema | 9 | 0.14% |
| Brain operation | 2 | 0.03% |
| Brain scan abnormal | 3 | 0.05% |
| Brain scan normal | 2 | 0.03% |
| Brain stem haemorrhage | 1 | 0.02% |
| Brain stem infarction | 1 | 0.02% |
| Brain stem stroke | 1 | 0.02% |
| Brain stem syndrome | 2 | 0.03% |
| Brain stem thrombosis | 1 | 0.02% |
| Breast cancer male | 1 | 0.02% |
| Breast discomfort | 4 | 0.06% |
| Breast mass | 2 | 0.03% |
| Breast operation | 1 | 0.02% |
| Breast pain | 16 | 0.25% |
| Breast prosthesis removal | 1 | 0.02% |
| Breast swelling | 3 | 0.05% |
| Breast tenderness | 1 | 0.02% |
| Breath holding | 1 | 0.02% |
| Breath sounds abnormal | 2 | 0.03% |
| Bronchial disorder | 1 | 0.02% |
| Bronchial hyperreactivity | 1 | 0.02% |
| Bronchiectasis | 1 | 0.02% |
| Bronchitis | 10 | 0.16% |
| Bronchitis bacterial | 1 | 0.02% |
| Bronchitis chronic | 1 | 0.02% |
| Bronchoalveolar lavage abnormal | 1 | 0.02% |
| Bronchoscopy | 1 | 0.02% |
| Bronchoscopy abnormal | 2 | 0.03% |
| Bruxism | 1 | 0.02% |
| Bulbar palsy | 1 | 0.02% |
| Bundle branch block | 2 | 0.03% |
| Bundle branch block left | 1 | 0.02% |
| Bundle branch block right | 5 | 0.08% |
| Burning sensation | 101 | 1.58% |
| Bursal fluid accumulation | 1 | 0.02% |
| Bursitis | 5 | 0.08% |
| Buttock injury | 1 | 0.02% |
| C-reactive protein | 23 | 0.36% |
| C-reactive protein decreased | 2 | 0.03% |
| C-reactive protein increased | 19 | 0.3% |
| C-reactive protein normal | 12 | 0.19% |
| Cachexia | 1 | 0.02% |
| Caesarean section | 2 | 0.03% |
| Calcinosis | 1 | 0.02% |
| Calcium ionised | 2 | 0.03% |
| Calcium ionised decreased | 1 | 0.02% |
| Calculus urethral | 1 | 0.02% |
| Campylobacter infection | 1 | 0.02% |
| Canalith repositioning procedure | 1 | 0.02% |
| Candida infection | 1 | 0.02% |
| Capillary fragility | 4 | 0.06% |
| Carbon dioxide | 1 | 0.02% |
| Carbon dioxide decreased | 10 | 0.16% |
| Carbon dioxide increased | 4 | 0.06% |
| Carbon dioxide normal | 16 | 0.25% |
| Cardiac ablation | 2 | 0.03% |
| Cardiac arrest | 28 | 0.44% |
| Cardiac assistance device user | 2 | 0.03% |
| Cardiac discomfort | 3 | 0.05% |
| Cardiac disorder | 13 | 0.2% |
| Cardiac failure | 6 | 0.09% |
| Cardiac failure acute | 2 | 0.03% |
| Cardiac failure chronic | 1 | 0.02% |
| Cardiac failure congestive | 16 | 0.25% |
| Cardiac flutter | 6 | 0.09% |
| Cardiac function test | 5 | 0.08% |
| Cardiac function test normal | 2 | 0.03% |
| Cardiac imaging procedure | 4 | 0.06% |
| Cardiac imaging procedure abnormal | 3 | 0.05% |
| Cardiac monitoring | 26 | 0.41% |
| Cardiac monitoring abnormal | 2 | 0.03% |
| Cardiac monitoring normal | 7 | 0.11% |
| Cardiac murmur | 3 | 0.05% |
| Cardiac operation | 1 | 0.02% |
| Cardiac pacemaker insertion | 4 | 0.06% |
| Cardiac perfusion defect | 1 | 0.02% |
| Cardiac septal defect repair | 1 | 0.02% |
| Cardiac stress test | 24 | 0.38% |
| Cardiac stress test abnormal | 5 | 0.08% |
| Cardiac stress test normal | 11 | 0.17% |
| Cardiac tamponade | 1 | 0.02% |
| Cardiac telemetry normal | 2 | 0.03% |
| Cardiac valve disease | 1 | 0.02% |
| Cardiac valve vegetation | 2 | 0.03% |
| Cardiac ventricular thrombosis | 1 | 0.02% |
| Cardiac ventriculogram left normal | 1 | 0.02% |
| Cardio-respiratory arrest | 6 | 0.09% |
| Cardiogenic shock | 1 | 0.02% |
| Cardiolipin antibody | 4 | 0.06% |
| Cardiolipin antibody negative | 4 | 0.06% |
| Cardiomegaly | 10 | 0.16% |
| Cardiomyopathy | 4 | 0.06% |
| Cardiopulmonary bypass | 1 | 0.02% |
| Cardiopulmonary exercise test | 1 | 0.02% |
| Cardiovascular disorder | 3 | 0.05% |
| Cardiovascular evaluation | 4 | 0.06% |
| Cardiovascular examination | 2 | 0.03% |
| Cardiovascular symptom | 2 | 0.03% |
| Cardioversion | 11 | 0.17% |
| Carditis | 2 | 0.03% |
| Carotid angioplasty | 1 | 0.02% |
| Carotid arteriosclerosis | 1 | 0.02% |
| Carotid artery aneurysm | 1 | 0.02% |
| Carotid artery occlusion | 4 | 0.06% |
| Carotid artery stenosis | 7 | 0.11% |
| Carotid artery thrombosis | 2 | 0.03% |
| Carotid endarterectomy | 1 | 0.02% |
| Carotidynia | 1 | 0.02% |
| Carpal tunnel syndrome | 1 | 0.02% |
| Cataract | 2 | 0.03% |
| Catheter directed thrombolysis | 3 | 0.05% |
| Catheterisation cardiac | 15 | 0.24% |
| Catheterisation cardiac abnormal | 11 | 0.17% |
| Catheterisation cardiac normal | 10 | 0.16% |
| Catheter site erythema | 1 | 0.02% |
| Catheter site haematoma | 1 | 0.02% |
| Catheter site haemorrhage | 1 | 0.02% |
| Catheter site swelling | 1 | 0.02% |
| Catheter site thrombosis | 1 | 0.02% |
| Catheter site warmth | 1 | 0.02% |
| Cauda equina syndrome | 1 | 0.02% |
| Cell marker increased | 1 | 0.02% |
| Cellulitis | 18 | 0.28% |
| Cellulitis orbital | 1 | 0.02% |
| Central nervous system immune reconstitution inflammatory response | 1 | 0.02% |
| Central nervous system inflammation | 1 | 0.02% |
| Central nervous system lesion | 5 | 0.08% |
| Central venous catheterisation | 7 | 0.11% |
| Central venous catheter removal | 1 | 0.02% |
| Central vision loss | 1 | 0.02% |
| Cerebellar embolism | 1 | 0.02% |
| Cerebellar haemorrhage | 1 | 0.02% |
| Cerebellar infarction | 2 | 0.03% |
| Cerebellar stroke | 5 | 0.08% |
| Cerebral artery embolism | 2 | 0.03% |
| Cerebral artery occlusion | 6 | 0.09% |
| Cerebral artery stenosis | 1 | 0.02% |
| Cerebral artery thrombosis | 3 | 0.05% |
| Cerebral atrophy | 1 | 0.02% |
| Cerebral disorder | 2 | 0.03% |
| Cerebral haematoma | 4 | 0.06% |
| Cerebral haemorrhage | 38 | 0.6% |
| Cerebral infarction | 13 | 0.2% |
| Cerebral ischaemia | 1 | 0.02% |
| Cerebral mass effect | 7 | 0.11% |
| Cerebral small vessel ischaemic disease | 1 | 0.02% |
| Cerebral thrombosis | 18 | 0.28% |
| Cerebral venous sinus thrombosis | 26 | 0.41% |
| Cerebral venous thrombosis | 4 | 0.06% |
| Cerebral ventricle dilatation | 1 | 0.02% |
| Cerebrospinal fluid drainage | 1 | 0.02% |
| Cerebrospinal fluid leakage | 1 | 0.02% |
| Cerebrospinal fluid retention | 1 | 0.02% |
| Cerebrovascular accident | 141 | 2.21% |
| Cerebrovascular disorder | 2 | 0.03% |
| Cerumen removal | 1 | 0.02% |
| Cervical spinal stenosis | 1 | 0.02% |
| Cervicitis trichomonal | 1 | 0.02% |
| Chapped lips | 2 | 0.03% |
| Chemotherapy | 2 | 0.03% |
| Chest discomfort | 285 | 4.47% |
| Chest pain | 538 | 8.43% |
| Chest scan | 1 | 0.02% |
| Chest tube insertion | 2 | 0.03% |
| Chest X-ray | 310 | 4.86% |
| Chest X-ray abnormal | 55 | 0.86% |
| Chest X-ray normal | 128 | 2.01% |
| Child maltreatment syndrome | 1 | 0.02% |
| Chills | 644 | 10.09% |
| Chlamydia test | 1 | 0.02% |
| Choking | 4 | 0.06% |
| Cholangiocarcinoma | 1 | 0.02% |
| Cholangitis | 1 | 0.02% |
| Cholangitis sclerosing | 1 | 0.02% |
| Cholecystectomy | 2 | 0.03% |
| Cholecystitis | 1 | 0.02% |
| Cholecystitis acute | 2 | 0.03% |
| Cholelithiasis | 4 | 0.06% |
| Chondritis | 1 | 0.02% |
| Chondrocalcinosis pyrophosphate | 1 | 0.02% |
| Chondrodystrophy | 1 | 0.02% |
| Chromaturia | 10 | 0.16% |
| Chronic inflammatory demyelinating polyradiculoneuropathy | 2 | 0.03% |
| Chronic obstructive pulmonary disease | 3 | 0.05% |
| Circadian rhythm sleep disorder | 1 | 0.02% |
| Circulatory collapse | 2 | 0.03% |
| Circumoral oedema | 1 | 0.02% |
| Circumoral swelling | 2 | 0.03% |
| Circumstantiality | 1 | 0.02% |
| Clonic convulsion | 1 | 0.02% |
| Clostridium difficile colitis | 1 | 0.02% |
| Clostridium test | 2 | 0.03% |
| Coagulation test | 10 | 0.16% |
| Coagulation test abnormal | 3 | 0.05% |
| Coagulation test normal | 6 | 0.09% |
| Coagulation time | 2 | 0.03% |
| Coagulation time prolonged | 1 | 0.02% |
| Coagulation time shortened | 1 | 0.02% |
| Coagulopathy | 6 | 0.09% |
| Coccydynia | 1 | 0.02% |
| Coeliac artery stenosis | 1 | 0.02% |
| Coeliac disease | 1 | 0.02% |
| Cognitive disorder | 12 | 0.19% |
| Cognitive test | 1 | 0.02% |
| Cold sweat | 87 | 1.36% |
| Colitis | 10 | 0.16% |
| Colitis ischaemic | 1 | 0.02% |
| Colitis ulcerative | 3 | 0.05% |
| Colon cancer metastatic | 1 | 0.02% |
| Colonoscopy | 11 | 0.17% |
| Colonoscopy abnormal | 3 | 0.05% |
| Colour blindness | 1 | 0.02% |
| Coma | 3 | 0.05% |
| Coma scale | 4 | 0.06% |
| Coma scale abnormal | 2 | 0.03% |
| Communication disorder | 3 | 0.05% |
| Complement factor C3 | 1 | 0.02% |
| Complement factor C4 | 1 | 0.02% |
| Completed suicide | 1 | 0.02% |
| Complication associated with device | 2 | 0.03% |
| Compression fracture | 1 | 0.02% |
| Compression garment application | 1 | 0.02% |
| Computerised tomogram | 515 | 8.07% |
| Computerised tomogram abdomen | 47 | 0.74% |
| Computerised tomogram abdomen abnormal | 20 | 0.31% |
| Computerised tomogram abdomen normal | 9 | 0.14% |
| Computerised tomogram abnormal | 70 | 1.1% |
| Computerised tomogram coronary artery | 3 | 0.05% |
| Computerised tomogram coronary artery abnormal | 2 | 0.03% |
| Computerised tomogram coronary artery normal | 1 | 0.02% |
| Computerised tomogram head | 157 | 2.46% |
| Computerised tomogram head abnormal | 74 | 1.16% |
| Computerised tomogram head normal | 59 | 0.92% |
| Computerised tomogram kidney abnormal | 1 | 0.02% |
| Computerised tomogram neck | 26 | 0.41% |
| Computerised tomogram normal | 159 | 2.49% |
| Computerised tomogram pelvis | 12 | 0.19% |
| Computerised tomogram pelvis abnormal | 3 | 0.05% |
| Computerised tomogram spine | 7 | 0.11% |
| Computerised tomogram thorax | 94 | 1.47% |
| Computerised tomogram thorax abnormal | 89 | 1.39% |
| Computerised tomogram thorax normal | 19 | 0.3% |
| Concussion | 8 | 0.13% |
| Condition aggravated | 169 | 2.65% |
| Confabulation | 1 | 0.02% |
| Confusional state | 125 | 1.96% |
| Congestive cardiomyopathy | 2 | 0.03% |
| Conjunctival haemorrhage | 1 | 0.02% |
| Conjunctivitis | 1 | 0.02% |
| Consciousness fluctuating | 6 | 0.09% |
| Constipation | 10 | 0.16% |
| Continuous haemodiafiltration | 1 | 0.02% |
| Contraception | 1 | 0.02% |
| Contrast media reaction | 1 | 0.02% |
| Contusion | 113 | 1.77% |
| Conversion disorder | 5 | 0.08% |
| Coombs direct test | 1 | 0.02% |
| Coombs indirect test | 1 | 0.02% |
| Coombs test negative | 1 | 0.02% |
| Coordination abnormal | 7 | 0.11% |
| Corneal reflex decreased | 2 | 0.03% |
| Coronary angioplasty | 2 | 0.03% |
| Coronary arterial stent insertion | 13 | 0.2% |
| Coronary artery bypass | 2 | 0.03% |
| Coronary artery disease | 3 | 0.05% |
| Coronary artery dissection | 2 | 0.03% |
| Coronary artery occlusion | 10 | 0.16% |
| Coronary artery stenosis | 4 | 0.06% |
| Coronary artery stent removal | 1 | 0.02% |
| Coronary artery thrombosis | 4 | 0.06% |
| Cor pulmonale | 1 | 0.02% |
| Cor pulmonale acute | 3 | 0.05% |
| Costochondritis | 2 | 0.03% |
| Cough | 199 | 3.12% |
| Cough decreased | 1 | 0.02% |
| COVID-19 | 126 | 1.97% |
| COVID-19 pneumonia | 20 | 0.31% |
| COVID-19 treatment | 1 | 0.02% |
| Coxsackie virus test | 1 | 0.02% |
| Cranial nerve disorder | 1 | 0.02% |
| Cranial nerve paralysis | 1 | 0.02% |
| Craniectomy | 1 | 0.02% |
| Craniocerebral injury | 3 | 0.05% |
| Craniotomy | 6 | 0.09% |
| Creatinine renal clearance increased | 1 | 0.02% |
| Creatinine renal clearance normal | 1 | 0.02% |
| Critical illness | 1 | 0.02% |
| Crohn's disease | 4 | 0.06% |
| Crying | 15 | 0.24% |
| Cryptococcus test | 2 | 0.03% |
| CSF cell count | 1 | 0.02% |
| CSF cell count normal | 1 | 0.02% |
| CSF culture negative | 4 | 0.06% |
| CSF glucose | 2 | 0.03% |
| CSF glucose decreased | 1 | 0.02% |
| CSF glucose increased | 1 | 0.02% |
| CSF immunoglobulin increased | 1 | 0.02% |
| CSF lactate | 1 | 0.02% |
| CSF oligoclonal band | 2 | 0.03% |
| CSF oligoclonal band absent | 1 | 0.02% |
| CSF protein | 3 | 0.05% |
| CSF protein increased | 13 | 0.2% |
| CSF protein normal | 1 | 0.02% |
| CSF test | 1 | 0.02% |
| CSF test abnormal | 4 | 0.06% |
| CSF virus no organisms observed | 1 | 0.02% |
| CSF white blood cell count decreased | 1 | 0.02% |
| CSF white blood cell count negative | 1 | 0.02% |
| CSF white blood cell differential | 1 | 0.02% |
| Culture | 2 | 0.03% |
| Culture negative | 2 | 0.03% |
| Culture stool | 4 | 0.06% |
| Culture stool negative | 1 | 0.02% |
| Culture tissue specimen | 1 | 0.02% |
| Culture urine | 24 | 0.38% |
| Culture urine negative | 7 | 0.11% |
| Culture urine positive | 2 | 0.03% |
| Cutaneous vasculitis | 3 | 0.05% |
| Cyanosis | 15 | 0.24% |
| Cyst | 3 | 0.05% |
| Cystitis | 7 | 0.11% |
| Cystoscopy normal | 1 | 0.02% |
| Cyst removal | 1 | 0.02% |
| Cytomegalovirus test | 1 | 0.02% |
| Cytomegalovirus test negative | 1 | 0.02% |
| Dacryostenosis acquired | 1 | 0.02% |
| Deafness | 10 | 0.16% |
| Deafness bilateral | 1 | 0.02% |
| Deafness neurosensory | 2 | 0.03% |
| Deafness unilateral | 10 | 0.16% |
| Death | 73 | 1.14% |
| Decerebrate posture | 1 | 0.02% |
| Decreased activity | 3 | 0.05% |
| Decreased appetite | 95 | 1.49% |
| Decreased eye contact | 1 | 0.02% |
| Decreased interest | 2 | 0.03% |
| Deep vein thrombosis | 216 | 3.38% |
| Defaecation urgency | 2 | 0.03% |
| Dehydration | 80 | 1.25% |
| Delirium | 6 | 0.09% |
| Delusion | 2 | 0.03% |
| Demyelinating polyneuropathy | 2 | 0.03% |
| Demyelination | 2 | 0.03% |
| Dental examination normal | 1 | 0.02% |
| Dependence on respirator | 1 | 0.02% |
| Depersonalisation/derealisation disorder | 1 | 0.02% |
| Depressed level of consciousness | 9 | 0.14% |
| Depressed mood | 2 | 0.03% |
| Depression | 17 | 0.27% |
| Dermal filler injection | 1 | 0.02% |
| Dermatitis | 1 | 0.02% |
| Dermatitis allergic | 3 | 0.05% |
| Dermatitis bullous | 1 | 0.02% |
| Dermatitis contact | 2 | 0.03% |
| Dermatochalasis | 1 | 0.02% |
| Device dislocation | 1 | 0.02% |
| Device function test | 1 | 0.02% |
| Device ineffective shock delivery | 1 | 0.02% |
| Device infusion issue | 1 | 0.02% |
| Diabetes mellitus | 8 | 0.13% |
| Diabetes mellitus inadequate control | 1 | 0.02% |
| Diabetic complication | 1 | 0.02% |
| Diabetic ketoacidosis | 1 | 0.02% |
| Diagnostic procedure | 2 | 0.03% |
| Dialysis | 3 | 0.05% |
| Diaphragmalgia | 1 | 0.02% |
| Diaphragm muscle weakness | 1 | 0.02% |
| Diarrhoea | 237 | 3.71% |
| Diarrhoea haemorrhagic | 7 | 0.11% |
| Diastolic dysfunction | 1 | 0.02% |
| Diet refusal | 2 | 0.03% |
| Differential white blood cell count | 49 | 0.77% |
| Differential white blood cell count abnormal | 2 | 0.03% |
| Differential white blood cell count normal | 21 | 0.33% |
| Diffuse large B-cell lymphoma | 1 | 0.02% |
| Diplegia | 5 | 0.08% |
| Diplopia | 29 | 0.45% |
| Disability | 2 | 0.03% |
| Discoloured vomit | 3 | 0.05% |
| Discomfort | 57 | 0.89% |
| Discouragement | 1 | 0.02% |
| Disease risk factor | 1 | 0.02% |
| Disorder of orbit | 1 | 0.02% |
| Disorganised speech | 5 | 0.08% |
| Disorientation | 56 | 0.88% |
| Disseminated intravascular coagulation | 3 | 0.05% |
| Disseminated varicella zoster virus infection | 1 | 0.02% |
| Dissociation | 1 | 0.02% |
| Disturbance in attention | 30 | 0.47% |
| Diuretic therapy | 1 | 0.02% |
| Diverticular perforation | 1 | 0.02% |
| Diverticulitis | 9 | 0.14% |
| Dizziness | 1,183 | 18.54% |
| Dizziness postural | 13 | 0.2% |
| DNA antibody negative | 1 | 0.02% |
| Double stranded DNA antibody | 5 | 0.08% |
| Drainage | 1 | 0.02% |
| Drain placement | 1 | 0.02% |
| Drain removal | 1 | 0.02% |
| Dreamy state | 1 | 0.02% |
| Drooling | 6 | 0.09% |
| Drug eruption | 1 | 0.02% |
| Drug screen | 4 | 0.06% |
| Drug screen negative | 5 | 0.08% |
| Drug screen positive | 1 | 0.02% |
| Drug trough level | 1 | 0.02% |
| Dry eye | 11 | 0.17% |
| Dry mouth | 31 | 0.49% |
| Dry skin | 8 | 0.13% |
| Dry throat | 9 | 0.14% |
| Dysaesthesia | 3 | 0.05% |
| Dysarthria | 60 | 0.94% |
| Dyschezia | 1 | 0.02% |
| Dyschromatopsia | 3 | 0.05% |
| Dysgeusia | 28 | 0.44% |
| Dysgraphia | 2 | 0.03% |
| Dyskinesia | 37 | 0.58% |
| Dyslexia | 1 | 0.02% |
| Dysmenorrhoea | 8 | 0.13% |
| Dysmetria | 1 | 0.02% |
| Dyspepsia | 27 | 0.42% |
| Dysphagia | 78 | 1.22% |
| Dysphemia | 6 | 0.09% |
| Dysphonia | 32 | 0.5% |
| Dyspnoea | 981 | 15.37% |
| Dyspnoea exertional | 27 | 0.42% |
| Dysstasia | 51 | 0.8% |
| Dystonia | 1 | 0.02% |
| Dysuria | 13 | 0.2% |
| Ear, nose and throat examination | 1 | 0.02% |
| Ear congestion | 3 | 0.05% |
| Ear discomfort | 34 | 0.53% |
| Ear disorder | 4 | 0.06% |
| Ear haemorrhage | 2 | 0.03% |
| Ear infection | 7 | 0.11% |
| Ear pain | 50 | 0.78% |
| Ear pruritus | 1 | 0.02% |
| Ear swelling | 5 | 0.08% |
| Eating disorder | 7 | 0.11% |
| Eating disorder symptom | 3 | 0.05% |
| Ecchymosis | 4 | 0.06% |
| Echocardiogram | 135 | 2.12% |
| Echocardiogram abnormal | 30 | 0.47% |
| Echocardiogram normal | 37 | 0.58% |
| Echovirus test | 1 | 0.02% |
| Ectopic pregnancy | 2 | 0.03% |
| Eczema | 2 | 0.03% |
| Eczema nummular | 1 | 0.02% |
| EGFR status assay | 3 | 0.05% |
| Ehrlichia test | 1 | 0.02% |
| Ejection fraction | 1 | 0.02% |
| Ejection fraction decreased | 5 | 0.08% |
| Ejection fraction normal | 1 | 0.02% |
| Electric shock | 1 | 0.02% |
| Electric shock sensation | 13 | 0.2% |
| Electrocardiogram | 544 | 8.52% |
| Electrocardiogram abnormal | 77 | 1.21% |
| Electrocardiogram ambulatory | 13 | 0.2% |
| Electrocardiogram ambulatory abnormal | 1 | 0.02% |
| Electrocardiogram ambulatory normal | 3 | 0.05% |
| Electrocardiogram change | 1 | 0.02% |
| Electrocardiogram normal | 223 | 3.49% |
| Electrocardiogram QRS complex prolonged | 1 | 0.02% |
| Electrocardiogram QT interval | 1 | 0.02% |
| Electrocardiogram QT prolonged | 1 | 0.02% |
| Electrocardiogram repolarisation abnormality | 1 | 0.02% |
| Electrocardiogram ST-T change | 2 | 0.03% |
| Electrocardiogram ST-T segment abnormal | 1 | 0.02% |
| Electrocardiogram ST segment abnormal | 2 | 0.03% |
| Electrocardiogram ST segment depression | 3 | 0.05% |
| Electrocardiogram ST segment elevation | 8 | 0.13% |
| Electrocardiogram T wave abnormal | 2 | 0.03% |
| Electrocardiogram T wave inversion | 1 | 0.02% |
| Electrocardiogram U wave present | 1 | 0.02% |
| Electroencephalogram | 20 | 0.31% |
| Electroencephalogram abnormal | 3 | 0.05% |
| Electroencephalogram normal | 9 | 0.14% |
| Electromyogram | 12 | 0.19% |
| Electromyogram abnormal | 4 | 0.06% |
| Electromyogram normal | 3 | 0.05% |
| Electronic cigarette user | 2 | 0.03% |
| Electrophoresis protein | 2 | 0.03% |
| Electrophoresis protein abnormal | 1 | 0.02% |
| Electrophoresis protein normal | 1 | 0.02% |
| Embolic stroke | 3 | 0.05% |
| Embolism | 4 | 0.06% |
| Embolism arterial | 1 | 0.02% |
| Emergency care | 1 | 0.02% |
| Emergency care examination | 1 | 0.02% |
| Emotional disorder | 2 | 0.03% |
| Emotional distress | 6 | 0.09% |
| Encephalitis | 3 | 0.05% |
| Encephalopathy | 3 | 0.05% |
| Endocarditis | 1 | 0.02% |
| Endodontic procedure | 1 | 0.02% |
| Endometriosis | 1 | 0.02% |
| Endoscopic retrograde cholangiopancreatography | 2 | 0.03% |
| Endoscopy | 13 | 0.2% |
| Endoscopy abnormal | 1 | 0.02% |
| Endoscopy normal | 1 | 0.02% |
| Endoscopy small intestine abnormal | 1 | 0.02% |
| Endoscopy upper gastrointestinal tract normal | 1 | 0.02% |
| Endotracheal intubation | 28 | 0.44% |
| Energy increased | 2 | 0.03% |
| Enlarged uvula | 4 | 0.06% |
| Enteral nutrition | 1 | 0.02% |
| Enterocolitis | 1 | 0.02% |
| Enterovirus test | 1 | 0.02% |
| Enterovirus test negative | 1 | 0.02% |
| Enuresis | 3 | 0.05% |
| Enzyme level abnormal | 1 | 0.02% |
| Enzyme level test | 2 | 0.03% |
| Eosinophil count | 2 | 0.03% |
| Eosinophil count decreased | 10 | 0.16% |
| Eosinophil count increased | 4 | 0.06% |
| Eosinophil count normal | 13 | 0.2% |
| Eosinophilic pneumonia chronic | 1 | 0.02% |
| Eosinophil percentage | 13 | 0.2% |
| Eosinophil percentage decreased | 4 | 0.06% |
| Eosinophil percentage increased | 2 | 0.03% |
| Epicondylitis | 1 | 0.02% |
| Epidural blood patch | 1 | 0.02% |
| Epidural injection | 1 | 0.02% |
| Epilepsy | 1 | 0.02% |
| Epinephrine | 3 | 0.05% |
| Epiploic appendagitis | 2 | 0.03% |
| Epistaxis | 32 | 0.5% |
| Epstein-Barr virus antibody | 1 | 0.02% |
| Epstein-Barr virus antibody positive | 2 | 0.03% |
| Epstein-Barr virus test | 1 | 0.02% |
| Epstein-Barr virus test negative | 1 | 0.02% |
| Erection increased | 2 | 0.03% |
| Eructation | 7 | 0.11% |
| Erythema | 140 | 2.19% |
| Erythema of eyelid | 2 | 0.03% |
| Erythroblast count normal | 1 | 0.02% |
| Erythrocyte osmotic fragility test | 1 | 0.02% |
| Escherichia infection | 1 | 0.02% |
| Escherichia test negative | 1 | 0.02% |
| Essential hypertension | 1 | 0.02% |
| Essential thrombocythaemia | 1 | 0.02% |
| Euphoric mood | 6 | 0.09% |
| Exaggerated startle response | 1 | 0.02% |
| Exercise electrocardiogram | 1 | 0.02% |
| Exercise tolerance decreased | 6 | 0.09% |
| Exophthalmos | 3 | 0.05% |
| Explorative laparotomy | 1 | 0.02% |
| Exposure during pregnancy | 30 | 0.47% |
| Exposure to SARS-CoV-2 | 10 | 0.16% |
| Exposure to toxic agent | 1 | 0.02% |
| Extra dose administered | 1 | 0.02% |
| Extraocular muscle paresis | 2 | 0.03% |
| Extrasystoles | 3 | 0.05% |
| Extremity contracture | 1 | 0.02% |
| Eye colour change | 1 | 0.02% |
| Eye contusion | 3 | 0.05% |
| Eye discharge | 5 | 0.08% |
| Eye disorder | 12 | 0.19% |
| Eye haemorrhage | 8 | 0.13% |
| Eye infarction | 1 | 0.02% |
| Eye infection | 1 | 0.02% |
| Eye infection bacterial | 1 | 0.02% |
| Eye inflammation | 2 | 0.03% |
| Eye injury | 2 | 0.03% |
| Eye irritation | 5 | 0.08% |
| Eyelid disorder | 9 | 0.14% |
| Eyelid function disorder | 5 | 0.08% |
| Eyelid oedema | 2 | 0.03% |
| Eyelid ptosis | 5 | 0.08% |
| Eyelid rash | 1 | 0.02% |
| Eyelid sensory disorder | 1 | 0.02% |
| Eye movement disorder | 46 | 0.72% |
| Eye operation | 1 | 0.02% |
| Eye pain | 57 | 0.89% |
| Eye patch application | 1 | 0.02% |
| Eye pruritus | 8 | 0.13% |
| Eye swelling | 29 | 0.45% |
| Eye ulcer | 1 | 0.02% |
| Face and mouth X-ray normal | 1 | 0.02% |
| Face injury | 14 | 0.22% |
| Face oedema | 2 | 0.03% |
| Facial asymmetry | 3 | 0.05% |
| Facial bones fracture | 3 | 0.05% |
| Facial discomfort | 5 | 0.08% |
| Facial nerve disorder | 2 | 0.03% |
| Facial neuralgia | 1 | 0.02% |
| Facial pain | 25 | 0.39% |
| Facial paralysis | 94 | 1.47% |
| Facial paresis | 14 | 0.22% |
| Factor II mutation | 3 | 0.05% |
| Factor V Leiden mutation | 6 | 0.09% |
| Faeces discoloured | 4 | 0.06% |
| Faeces hard | 1 | 0.02% |
| Faeces pale | 1 | 0.02% |
| Fall | 229 | 3.59% |
| Fallopian tube disorder | 1 | 0.02% |
| Fallopian tube operation | 1 | 0.02% |
| Fasciotomy | 1 | 0.02% |
| Fatigue | 831 | 13.02% |
| Fear | 7 | 0.11% |
| Fear of injection | 5 | 0.08% |
| Feeding disorder | 28 | 0.44% |
| Feeling abnormal | 303 | 4.75% |
| Feeling cold | 77 | 1.21% |
| Feeling drunk | 11 | 0.17% |
| Feeling guilty | 1 | 0.02% |
| Feeling hot | 132 | 2.07% |
| Feeling jittery | 12 | 0.19% |
| Feeling of body temperature change | 15 | 0.24% |
| Female sex hormone level | 1 | 0.02% |
| Fibrin D dimer | 129 | 2.02% |
| Fibrin D dimer decreased | 1 | 0.02% |
| Fibrin D dimer increased | 98 | 1.54% |
| Fibrin D dimer normal | 45 | 0.71% |
| Fibromyalgia | 3 | 0.05% |
| Fibrosis | 1 | 0.02% |
| Fine motor skill dysfunction | 5 | 0.08% |
| Finger deformity | 1 | 0.02% |
| Flank pain | 18 | 0.28% |
| Flat affect | 1 | 0.02% |
| Flat chest | 1 | 0.02% |
| Flatulence | 9 | 0.14% |
| Flight of ideas | 1 | 0.02% |
| Flow cytometry | 1 | 0.02% |
| Fluid intake reduced | 2 | 0.03% |
| Fluid overload | 2 | 0.03% |
| Fluid replacement | 7 | 0.11% |
| Fluid retention | 11 | 0.17% |
| Flushing | 107 | 1.68% |
| Foaming at mouth | 11 | 0.17% |
| Foetal heart rate abnormal | 1 | 0.02% |
| Foetal hypokinesia | 1 | 0.02% |
| Foetal monitoring | 2 | 0.03% |
| Follicular lymphoma | 1 | 0.02% |
| Food allergy | 2 | 0.03% |
| Food interaction | 1 | 0.02% |
| Food intolerance | 1 | 0.02% |
| Foot deformity | 1 | 0.02% |
| Foot fracture | 2 | 0.03% |
| Forceps delivery | 1 | 0.02% |
| Foreign body in ear | 1 | 0.02% |
| Foreign body in eye | 1 | 0.02% |
| Foreign body in throat | 1 | 0.02% |
| Formication | 3 | 0.05% |
| Fracture | 1 | 0.02% |
| Freezing phenomenon | 2 | 0.03% |
| Frequent bowel movements | 5 | 0.08% |
| Frustration tolerance decreased | 1 | 0.02% |
| Full blood count | 259 | 4.06% |
| Full blood count abnormal | 13 | 0.2% |
| Full blood count normal | 116 | 1.82% |
| Fundoscopy | 1 | 0.02% |
| Fungal infection | 1 | 0.02% |
| Fungal test | 1 | 0.02% |
| Furuncle | 1 | 0.02% |
| Gait disturbance | 138 | 2.16% |
| Gait inability | 50 | 0.78% |
| Gamma-glutamyltransferase increased | 1 | 0.02% |
| Gamma-glutamyltransferase normal | 1 | 0.02% |
| Gangrene | 1 | 0.02% |
| Gastric dilatation | 1 | 0.02% |
| Gastric disorder | 2 | 0.03% |
| Gastric emptying study | 1 | 0.02% |
| Gastric haemorrhage | 3 | 0.05% |
| Gastric ulcer | 4 | 0.06% |
| Gastritis | 1 | 0.02% |
| Gastrocardiac syndrome | 1 | 0.02% |
| Gastroenteritis | 2 | 0.03% |
| Gastroenteritis viral | 4 | 0.06% |
| Gastrointestinal arteriovenous malformation | 1 | 0.02% |
| Gastrointestinal disorder | 11 | 0.17% |
| Gastrointestinal haemorrhage | 3 | 0.05% |
| Gastrointestinal inflammation | 4 | 0.06% |
| Gastrointestinal motility disorder | 2 | 0.03% |
| Gastrointestinal pain | 10 | 0.16% |
| Gastrointestinal pathogen panel | 2 | 0.03% |
| Gastrointestinal sounds abnormal | 2 | 0.03% |
| Gastrointestinal tube insertion | 1 | 0.02% |
| Gastrooesophageal reflux disease | 13 | 0.2% |
| Gastrostomy | 1 | 0.02% |
| Gaze palsy | 14 | 0.22% |
| Gene mutation identification test | 1 | 0.02% |
| Gene mutation identification test negative | 3 | 0.05% |
| Generalised anxiety disorder | 1 | 0.02% |
| Generalised oedema | 4 | 0.06% |
| Generalised tonic-clonic seizure | 20 | 0.31% |
| General physical condition abnormal | 1 | 0.02% |
| General physical health deterioration | 9 | 0.14% |
| General symptom | 2 | 0.03% |
| Genital discomfort | 2 | 0.03% |
| Genital herpes | 1 | 0.02% |
| Genital pain | 1 | 0.02% |
| Giant cell arteritis | 5 | 0.08% |
| Giardia test negative | 1 | 0.02% |
| Gingival bleeding | 3 | 0.05% |
| Gingival pain | 2 | 0.03% |
| Gingival swelling | 2 | 0.03% |
| Gingival ulceration | 1 | 0.02% |
| Gingivitis | 1 | 0.02% |
| Glassy eyes | 4 | 0.06% |
| Globulin | 5 | 0.08% |
| Globulins decreased | 1 | 0.02% |
| Globulins increased | 3 | 0.05% |
| Glomerular filtration rate | 14 | 0.22% |
| Glomerular filtration rate decreased | 12 | 0.19% |
| Glomerular filtration rate increased | 2 | 0.03% |
| Glomerular filtration rate normal | 10 | 0.16% |
| Glossitis | 1 | 0.02% |
| Glossodynia | 2 | 0.03% |
| Glucose urine absent | 7 | 0.11% |
| Gluten sensitivity | 1 | 0.02% |
| Glycosylated haemoglobin | 8 | 0.13% |
| Glycosylated haemoglobin increased | 5 | 0.08% |
| Glycosylated haemoglobin normal | 9 | 0.14% |
| Goitre | 1 | 0.02% |
| Granulocyte percentage | 2 | 0.03% |
| Grimacing | 1 | 0.02% |
| Grip strength decreased | 6 | 0.09% |
| Groin pain | 17 | 0.27% |
| Growing pains | 1 | 0.02% |
| Grunting | 2 | 0.03% |
| Guillain-Barre syndrome | 51 | 0.8% |
| Gynaecological examination | 1 | 0.02% |
| Haemangioma of liver | 1 | 0.02% |
| Haemangioma of skin | 1 | 0.02% |
| Haematemesis | 14 | 0.22% |
| Haematochezia | 16 | 0.25% |
| Haematocrit | 7 | 0.11% |
| Haematocrit decreased | 17 | 0.27% |
| Haematocrit increased | 6 | 0.09% |
| Haematocrit normal | 36 | 0.56% |
| Haematology test | 4 | 0.06% |
| Haematology test normal | 1 | 0.02% |
| Haematoma | 6 | 0.09% |
| Haematotympanum | 1 | 0.02% |
| Haematuria | 7 | 0.11% |
| Haemodialysis | 2 | 0.03% |
| Haemodynamic test | 1 | 0.02% |
| Haemoglobin | 11 | 0.17% |
| Haemoglobin decreased | 41 | 0.64% |
| Haemoglobin increased | 3 | 0.05% |
| Haemoglobin normal | 43 | 0.67% |
| Haemolysis | 1 | 0.02% |
| Haemolytic uraemic syndrome | 1 | 0.02% |
| Haemoperitoneum | 2 | 0.03% |
| Haemophilus test | 1 | 0.02% |
| Haemoptysis | 20 | 0.31% |
| Haemorrhage | 15 | 0.24% |
| Haemorrhage in pregnancy | 2 | 0.03% |
| Haemorrhage intracranial | 4 | 0.06% |
| Haemorrhage urinary tract | 3 | 0.05% |
| Haemorrhagic disorder | 1 | 0.02% |
| Haemorrhagic ovarian cyst | 1 | 0.02% |
| Haemorrhagic stroke | 7 | 0.11% |
| Haemorrhagic transformation stroke | 1 | 0.02% |
| Haemorrhoid operation | 1 | 0.02% |
| Haemorrhoids | 3 | 0.05% |
| Haemorrhoids thrombosed | 2 | 0.03% |
| Hallucination | 16 | 0.25% |
| Hallucination, auditory | 1 | 0.02% |
| Hallucination, visual | 1 | 0.02% |
| Hallucinations, mixed | 1 | 0.02% |
| Hand deformity | 1 | 0.02% |
| Hangover | 1 | 0.02% |
| Haptoglobin | 1 | 0.02% |
| Haptoglobin decreased | 1 | 0.02% |
| Headache | 1,422 | 22.28% |
| Head discomfort | 61 | 0.96% |
| Head injury | 97 | 1.52% |
| Head titubation | 1 | 0.02% |
| Hearing disability | 1 | 0.02% |
| Heart injury | 2 | 0.03% |
| Heart rate | 62 | 0.97% |
| Heart rate abnormal | 11 | 0.17% |
| Heart rate decreased | 37 | 0.58% |
| Heart rate increased | 250 | 3.92% |
| Heart rate irregular | 31 | 0.49% |
| Heart rate normal | 5 | 0.08% |
| Heart rate variability test | 1 | 0.02% |
| Heavy menstrual bleeding | 25 | 0.39% |
| Helicobacter infection | 1 | 0.02% |
| Helicobacter test | 1 | 0.02% |
| Hemiparaesthesia | 2 | 0.03% |
| Hemiparesis | 45 | 0.71% |
| Hemiplegia | 12 | 0.19% |
| Hemiplegic migraine | 1 | 0.02% |
| Henoch-Schonlein purpura | 1 | 0.02% |
| Heparin-induced thrombocytopenia | 1 | 0.02% |
| Heparin-induced thrombocytopenia test | 5 | 0.08% |
| Heparin-induced thrombocytopenia test positive | 4 | 0.06% |
| Hepatic artery thrombosis | 1 | 0.02% |
| Hepatic enzyme | 4 | 0.06% |
| Hepatic enzyme abnormal | 2 | 0.03% |
| Hepatic enzyme increased | 5 | 0.08% |
| Hepatic failure | 1 | 0.02% |
| Hepatic function abnormal | 2 | 0.03% |
| Hepatic mass | 1 | 0.02% |
| Hepatic steatosis | 5 | 0.08% |
| Hepatitis | 1 | 0.02% |
| Hepatitis B core antibody positive | 1 | 0.02% |
| Hepatitis B DNA assay negative | 1 | 0.02% |
| Hepatitis B DNA increased | 1 | 0.02% |
| Hepatitis B surface antigen negative | 2 | 0.03% |
| Hepatitis B surface antigen positive | 1 | 0.02% |
| Hepatitis B test negative | 1 | 0.02% |
| Hepatitis B virus test | 2 | 0.03% |
| Hepatitis C antibody | 1 | 0.02% |
| Hepatitis C antibody positive | 1 | 0.02% |
| Hepatitis C RNA negative | 1 | 0.02% |
| Hepatitis C virus test | 1 | 0.02% |
| Hepatitis viral test | 1 | 0.02% |
| Hepatitis viral test negative | 1 | 0.02% |
| Hepatocellular carcinoma | 1 | 0.02% |
| Hepatomegaly | 2 | 0.03% |
| Hepatosplenomegaly | 1 | 0.02% |
| Hernial eventration | 1 | 0.02% |
| Herpes ophthalmic | 1 | 0.02% |
| Herpes simplex | 1 | 0.02% |
| Herpes simplex test | 1 | 0.02% |
| Herpes simplex test negative | 2 | 0.03% |
| Herpes virus infection | 2 | 0.03% |
| Herpes virus test | 1 | 0.02% |
| Herpes zoster | 46 | 0.72% |
| Herpes zoster oticus | 1 | 0.02% |
| Hiatus hernia | 3 | 0.05% |
| Hidradenitis | 1 | 0.02% |
| High density lipoprotein decreased | 1 | 0.02% |
| High density lipoprotein normal | 3 | 0.05% |
| Hilar lymphadenopathy | 1 | 0.02% |
| Hip fracture | 2 | 0.03% |
| HIV antibody negative | 2 | 0.03% |
| HIV antigen negative | 2 | 0.03% |
| HIV test | 1 | 0.02% |
| HIV test negative | 9 | 0.14% |
| Hormone level abnormal | 1 | 0.02% |
| Hospitalisation | 4 | 0.06% |
| Hot flush | 31 | 0.49% |
| Human chorionic gonadotropin | 10 | 0.16% |
| Human chorionic gonadotropin decreased | 1 | 0.02% |
| Human chorionic gonadotropin negative | 6 | 0.09% |
| Human chorionic gonadotropin positive | 1 | 0.02% |
| Human ehrlichiosis | 1 | 0.02% |
| Human rhinovirus test positive | 1 | 0.02% |
| Humerus fracture | 1 | 0.02% |
| Hunger | 2 | 0.03% |
| Hunt and Hess scale | 1 | 0.02% |
| Hydrocephalus | 2 | 0.03% |
| Hydronephrosis | 1 | 0.02% |
| Hyperacusis | 12 | 0.19% |
| Hyperaesthesia | 12 | 0.19% |
| Hyperaesthesia teeth | 1 | 0.02% |
| Hyperbilirubinaemia | 1 | 0.02% |
| Hypercapnia | 2 | 0.03% |
| Hypercoagulation | 2 | 0.03% |
| Hyperglycaemia | 8 | 0.13% |
| Hyperhidrosis | 378 | 5.92% |
| Hyperkalaemia | 3 | 0.05% |
| Hyperlipidaemia | 1 | 0.02% |
| Hypernatraemia | 1 | 0.02% |
| Hyperplasia | 1 | 0.02% |
| Hyperpyrexia | 2 | 0.03% |
| Hyperreflexia | 1 | 0.02% |
| Hypersensitivity | 60 | 0.94% |
| Hypersensitivity vasculitis | 1 | 0.02% |
| Hypersomnia | 28 | 0.44% |
| Hypertension | 179 | 2.8% |
| Hypertensive crisis | 4 | 0.06% |
| Hypertensive emergency | 1 | 0.02% |
| Hypertensive encephalopathy | 1 | 0.02% |
| Hypertensive urgency | 1 | 0.02% |
| Hyperthyroidism | 5 | 0.08% |
| Hypertrophic cardiomyopathy | 1 | 0.02% |
| Hypertrophy of tongue papillae | 1 | 0.02% |
| Hyperventilation | 21 | 0.33% |
| Hyphaema | 1 | 0.02% |
| Hypoacusis | 18 | 0.28% |
| Hypoaesthesia | 505 | 7.91% |
| Hypoaesthesia eye | 3 | 0.05% |
| Hypoaesthesia oral | 69 | 1.08% |
| Hypochromasia | 1 | 0.02% |
| Hypogeusia | 1 | 0.02% |
| Hypoglossal nerve paralysis | 1 | 0.02% |
| Hypoglycaemia | 7 | 0.11% |
| Hypokalaemia | 7 | 0.11% |
| Hypokinesia | 12 | 0.19% |
| Hypomagnesaemia | 1 | 0.02% |
| Hypomenorrhoea | 1 | 0.02% |
| Hyponatraemia | 8 | 0.13% |
| Hypoosmolar state | 2 | 0.03% |
| Hypophagia | 4 | 0.06% |
| Hypopnoea | 15 | 0.24% |
| Hyporeflexia | 1 | 0.02% |
| Hyporesponsive to stimuli | 2 | 0.03% |
| Hyposmia | 1 | 0.02% |
| Hypotension | 126 | 1.97% |
| Hypothermia | 4 | 0.06% |
| Hypothyroidism | 5 | 0.08% |
| Hypotonia | 10 | 0.16% |
| Hypovolaemic shock | 1 | 0.02% |
| Hypoxia | 25 | 0.39% |
| Hypoxic-ischaemic encephalopathy | 1 | 0.02% |
| Hysterectomy | 2 | 0.03% |
| Hysteroscopy abnormal | 1 | 0.02% |
| Idiopathic intracranial hypertension | 3 | 0.05% |
| IIIrd nerve paralysis | 1 | 0.02% |
| Iliac artery embolism | 1 | 0.02% |
| Iliac artery occlusion | 1 | 0.02% |
| Illiteracy | 2 | 0.03% |
| Illness | 19 | 0.3% |
| Illusion | 1 | 0.02% |
| Imaging procedure | 8 | 0.13% |
| Immature granulocyte count | 10 | 0.16% |
| Immature granulocyte count increased | 3 | 0.05% |
| Immature granulocyte percentage increased | 1 | 0.02% |
| Immediate post-injection reaction | 106 | 1.66% |
| Immobile | 1 | 0.02% |
| Immune system disorder | 3 | 0.05% |
| Immune thrombocytopenia | 13 | 0.2% |
| Immunodeficiency | 1 | 0.02% |
| Immunoelectrophoresis | 1 | 0.02% |
| Immunoglobulins | 1 | 0.02% |
| Immunoglobulins abnormal | 1 | 0.02% |
| Immunoglobulins decreased | 1 | 0.02% |
| Immunoglobulin therapy | 44 | 0.69% |
| Immunohistochemistry | 2 | 0.03% |
| Immunology test | 10 | 0.16% |
| Immunosuppressant drug therapy | 1 | 0.02% |
| Impaired driving ability | 29 | 0.45% |
| Impaired work ability | 107 | 1.68% |
| Implantable cardiac monitor insertion | 1 | 0.02% |
| Inappropriate affect | 2 | 0.03% |
| Inappropriate schedule of product administration | 3 | 0.05% |
| Incision site pain | 1 | 0.02% |
| Incoherent | 12 | 0.19% |
| Incontinence | 6 | 0.09% |
| Incorrect dose administered | 5 | 0.08% |
| Incorrect product formulation administered | 1 | 0.02% |
| Incorrect route of product administration | 2 | 0.03% |
| Increased insulin requirement | 1 | 0.02% |
| Increased tendency to bruise | 4 | 0.06% |
| Increased upper airway secretion | 1 | 0.02% |
| Increased viscosity of upper respiratory secretion | 2 | 0.03% |
| Indeterminable ABO blood type | 1 | 0.02% |
| Induced labour | 1 | 0.02% |
| Induration | 16 | 0.25% |
| Infarction | 3 | 0.05% |
| Infected bite | 1 | 0.02% |
| Infection | 10 | 0.16% |
| Inferior vena cava dilatation | 1 | 0.02% |
| Inflammation | 47 | 0.74% |
| Inflammatory marker increased | 2 | 0.03% |
| Inflammatory marker test | 2 | 0.03% |
| Influenza | 10 | 0.16% |
| Influenza A virus test | 5 | 0.08% |
| Influenza A virus test negative | 12 | 0.19% |
| Influenza B virus test | 14 | 0.22% |
| Influenza like illness | 112 | 1.75% |
| Influenza virus test | 12 | 0.19% |
| Influenza virus test negative | 18 | 0.28% |
| Infusion | 4 | 0.06% |
| Infusion site extravasation | 1 | 0.02% |
| Initial insomnia | 4 | 0.06% |
| Injected limb mobility decreased | 3 | 0.05% |
| Injection | 1 | 0.02% |
| Injection site bruising | 12 | 0.19% |
| Injection site cellulitis | 3 | 0.05% |
| Injection site discomfort | 4 | 0.06% |
| Injection site erythema | 41 | 0.64% |
| Injection site extravasation | 2 | 0.03% |
| Injection site haemorrhage | 2 | 0.03% |
| Injection site hypoaesthesia | 4 | 0.06% |
| Injection site induration | 4 | 0.06% |
| Injection site infection | 2 | 0.03% |
| Injection site irritation | 2 | 0.03% |
| Injection site joint pain | 1 | 0.02% |
| Injection site mass | 14 | 0.22% |
| Injection site movement impairment | 1 | 0.02% |
| Injection site nodule | 5 | 0.08% |
| Injection site pain | 182 | 2.85% |
| Injection site paraesthesia | 3 | 0.05% |
| Injection site pruritus | 17 | 0.27% |
| Injection site rash | 21 | 0.33% |
| Injection site reaction | 7 | 0.11% |
| Injection site streaking | 1 | 0.02% |
| Injection site swelling | 46 | 0.72% |
| Injection site vesicles | 3 | 0.05% |
| Injection site warmth | 14 | 0.22% |
| Injury | 9 | 0.14% |
| Inner ear disorder | 1 | 0.02% |
| Inner ear inflammation | 1 | 0.02% |
| Insomnia | 90 | 1.41% |
| Inspiratory capacity decreased | 1 | 0.02% |
| Intensive care | 70 | 1.1% |
| Interchange of vaccine products | 11 | 0.17% |
| Intermenstrual bleeding | 7 | 0.11% |
| Internal device exposed | 1 | 0.02% |
| International normalised ratio | 25 | 0.39% |
| International normalised ratio decreased | 1 | 0.02% |
| International normalised ratio increased | 12 | 0.19% |
| International normalised ratio normal | 33 | 0.52% |
| Intervertebral disc compression | 1 | 0.02% |
| Intervertebral disc degeneration | 2 | 0.03% |
| Intervertebral disc operation | 1 | 0.02% |
| Intervertebral disc protrusion | 4 | 0.06% |
| Intervertebral disc space narrowing | 1 | 0.02% |
| Intestinal congestion | 1 | 0.02% |
| Intestinal ischaemia | 1 | 0.02% |
| Intestinal obstruction | 1 | 0.02% |
| Intra-abdominal pressure increased | 1 | 0.02% |
| Intra-aortic balloon placement | 1 | 0.02% |
| Intracardiac mass | 1 | 0.02% |
| Intracardiac thrombus | 4 | 0.06% |
| Intracranial aneurysm | 4 | 0.06% |
| Intracranial mass | 1 | 0.02% |
| Intracranial pressure increased | 1 | 0.02% |
| Intranasal paraesthesia | 1 | 0.02% |
| Intraocular pressure decreased | 1 | 0.02% |
| Intraocular pressure increased | 2 | 0.03% |
| Intraocular pressure test | 3 | 0.05% |
| Intraventricular haemorrhage | 2 | 0.03% |
| Intrusive thoughts | 1 | 0.02% |
| Investigation | 10 | 0.16% |
| Investigation normal | 1 | 0.02% |
| Iron binding capacity total normal | 3 | 0.05% |
| Iron deficiency anaemia | 1 | 0.02% |
| Irregular breathing | 3 | 0.05% |
| Irritability | 3 | 0.05% |
| Irritable bowel syndrome | 3 | 0.05% |
| Ischaemia | 1 | 0.02% |
| Ischaemic stroke | 18 | 0.28% |
| ISTH score for disseminated intravascular coagulation | 1 | 0.02% |
| IVth nerve paralysis | 2 | 0.03% |
| Jaundice | 2 | 0.03% |
| Jaw disorder | 4 | 0.06% |
| Jaw fracture | 1 | 0.02% |
| Joint contracture | 2 | 0.03% |
| Joint dislocation | 4 | 0.06% |
| Joint dislocation reduction | 1 | 0.02% |
| Joint effusion | 6 | 0.09% |
| Joint fluid drainage | 1 | 0.02% |
| Joint injury | 4 | 0.06% |
| Joint instability | 1 | 0.02% |
| Joint lock | 2 | 0.03% |
| Joint range of motion decreased | 6 | 0.09% |
| Joint stiffness | 10 | 0.16% |
| Joint swelling | 54 | 0.85% |
| Judgement impaired | 1 | 0.02% |
| Jugular vein distension | 1 | 0.02% |
| Jugular vein thrombosis | 7 | 0.11% |
| Keratosis pilaris | 1 | 0.02% |
| Kidney infection | 5 | 0.08% |
| Knee operation | 1 | 0.02% |
| Labile blood pressure | 1 | 0.02% |
| Labile hypertension | 1 | 0.02% |
| Laboratory test | 345 | 5.41% |
| Laboratory test abnormal | 19 | 0.3% |
| Laboratory test interference | 1 | 0.02% |
| Laboratory test normal | 96 | 1.5% |
| Labour pain | 1 | 0.02% |
| Labyrinthitis | 3 | 0.05% |
| Lack of spontaneous speech | 1 | 0.02% |
| Lacrimation increased | 18 | 0.28% |
| Lactic acidosis | 3 | 0.05% |
| Lacunar infarction | 2 | 0.03% |
| Lacunar stroke | 2 | 0.03% |
| Laparoscopic surgery | 3 | 0.05% |
| Large intestine perforation | 1 | 0.02% |
| Laryngitis | 2 | 0.03% |
| LDL/HDL ratio | 2 | 0.03% |
| Left ventricular dysfunction | 6 | 0.09% |
| Left ventricular enlargement | 1 | 0.02% |
| Left ventricular failure | 2 | 0.03% |
| Left ventricular hypertrophy | 1 | 0.02% |
| Legionella test | 1 | 0.02% |
| Leptospirosis | 1 | 0.02% |
| Lethargy | 71 | 1.11% |
| Leukocytosis | 4 | 0.06% |
| Leukopenia | 1 | 0.02% |
| Libido decreased | 1 | 0.02% |
| Life support | 5 | 0.08% |
| Ligamentitis | 1 | 0.02% |
| Ligament rupture | 1 | 0.02% |
| Ligament sprain | 1 | 0.02% |
| Limb discomfort | 65 | 1.02% |
| Limb injury | 4 | 0.06% |
| Limb mass | 7 | 0.11% |
| Lipase | 23 | 0.36% |
| Lipase increased | 2 | 0.03% |
| Lipase normal | 10 | 0.16% |
| Lip discolouration | 1 | 0.02% |
| Lip dry | 1 | 0.02% |
| Lipids | 6 | 0.09% |
| Lipids abnormal | 1 | 0.02% |
| Lipids increased | 1 | 0.02% |
| Lipids normal | 4 | 0.06% |
| Lip injury | 6 | 0.09% |
| Lip oedema | 1 | 0.02% |
| Lipoma | 1 | 0.02% |
| Lip pain | 1 | 0.02% |
| Lip pruritus | 5 | 0.08% |
| Lip swelling | 65 | 1.02% |
| Lip ulceration | 1 | 0.02% |
| Listeria test | 1 | 0.02% |
| Liver function test | 11 | 0.17% |
| Liver function test abnormal | 1 | 0.02% |
| Liver function test decreased | 2 | 0.03% |
| Liver function test increased | 7 | 0.11% |
| Liver function test normal | 8 | 0.13% |
| Liver injury | 1 | 0.02% |
| Localised infection | 2 | 0.03% |
| Local reaction | 1 | 0.02% |
| Loose tooth | 1 | 0.02% |
| Loss of bladder sensation | 1 | 0.02% |
| Loss of consciousness | 417 | 6.53% |
| Loss of control of legs | 1 | 0.02% |
| Loss of personal independence in daily activities | 59 | 0.92% |
| Low density lipoprotein | 1 | 0.02% |
| Low density lipoprotein increased | 2 | 0.03% |
| Low density lipoprotein normal | 3 | 0.05% |
| Lower respiratory tract infection | 1 | 0.02% |
| Lumbar puncture | 46 | 0.72% |
| Lumbar puncture abnormal | 16 | 0.25% |
| Lumbar puncture normal | 6 | 0.09% |
| Lumbar spinal stenosis | 1 | 0.02% |
| Lung assist device therapy | 1 | 0.02% |
| Lung consolidation | 3 | 0.05% |
| Lung disorder | 5 | 0.08% |
| Lung infiltration | 11 | 0.17% |
| Lung neoplasm malignant | 1 | 0.02% |
| Lung opacity | 20 | 0.31% |
| Lyme disease | 3 | 0.05% |
| Lymphadenitis | 3 | 0.05% |
| Lymphadenopathy | 57 | 0.89% |
| Lymph gland infection | 1 | 0.02% |
| Lymph node pain | 8 | 0.13% |
| Lymphocyte count | 11 | 0.17% |
| Lymphocyte count decreased | 6 | 0.09% |
| Lymphocyte count increased | 7 | 0.11% |
| Lymphocyte count normal | 13 | 0.2% |
| Lymphocyte morphology abnormal | 1 | 0.02% |
| Lymphocyte percentage | 14 | 0.22% |
| Lymphocyte percentage decreased | 11 | 0.17% |
| Lymphocyte percentage increased | 4 | 0.06% |
| Lymphocytosis | 1 | 0.02% |
| Lymphopenia | 1 | 0.02% |
| Magnetic resonance imaging | 240 | 3.76% |
| Magnetic resonance imaging abdominal | 1 | 0.02% |
| Magnetic resonance imaging abdominal abnormal | 2 | 0.03% |
| Magnetic resonance imaging abdominal normal | 1 | 0.02% |
| Magnetic resonance imaging abnormal | 33 | 0.52% |
| Magnetic resonance imaging head | 87 | 1.36% |
| Magnetic resonance imaging head abnormal | 87 | 1.36% |
| Magnetic resonance imaging head normal | 47 | 0.74% |
| Magnetic resonance imaging heart | 6 | 0.09% |
| Magnetic resonance imaging hepatobiliary | 1 | 0.02% |
| Magnetic resonance imaging neck | 21 | 0.33% |
| Magnetic resonance imaging normal | 59 | 0.92% |
| Magnetic resonance imaging spinal | 17 | 0.27% |
| Magnetic resonance imaging spinal abnormal | 13 | 0.2% |
| Magnetic resonance imaging spinal normal | 4 | 0.06% |
| Magnetic resonance imaging thoracic | 6 | 0.09% |
| Magnetic resonance imaging thoracic abnormal | 2 | 0.03% |
| Magnetic resonance imaging thoracic normal | 1 | 0.02% |
| Malaise | 293 | 4.59% |
| Male genital examination abnormal | 1 | 0.02% |
| Malocclusion | 1 | 0.02% |
| Mammogram | 4 | 0.06% |
| Mania | 1 | 0.02% |
| Mass | 1 | 0.02% |
| Mastication disorder | 5 | 0.08% |
| Maternal exposure before pregnancy | 2 | 0.03% |
| Maternal exposure during breast feeding | 1 | 0.02% |
| Maximal voluntary ventilation | 1 | 0.02% |
| Mean cell haemoglobin | 3 | 0.05% |
| Mean cell haemoglobin concentration | 2 | 0.03% |
| Mean cell haemoglobin concentration decreased | 6 | 0.09% |
| Mean cell haemoglobin concentration increased | 2 | 0.03% |
| Mean cell haemoglobin concentration normal | 25 | 0.39% |
| Mean cell haemoglobin decreased | 3 | 0.05% |
| Mean cell haemoglobin increased | 8 | 0.13% |
| Mean cell haemoglobin normal | 19 | 0.3% |
| Mean cell volume | 3 | 0.05% |
| Mean cell volume decreased | 2 | 0.03% |
| Mean cell volume increased | 5 | 0.08% |
| Mean cell volume normal | 27 | 0.42% |
| Mean platelet volume | 1 | 0.02% |
| Mean platelet volume decreased | 1 | 0.02% |
| Mean platelet volume increased | 8 | 0.13% |
| Mean platelet volume normal | 17 | 0.27% |
| Mechanical ventilation | 17 | 0.27% |
| Mediastinal mass | 1 | 0.02% |
| Medical device site burn | 1 | 0.02% |
| Medical diet | 2 | 0.03% |
| Medical induction of coma | 1 | 0.02% |
| Medication error | 1 | 0.02% |
| Melaena | 3 | 0.05% |
| Memory impairment | 20 | 0.31% |
| Meniere's disease | 1 | 0.02% |
| Meningioma | 2 | 0.03% |
| Meningitis | 1 | 0.02% |
| Meniscus injury | 1 | 0.02% |
| Menopausal symptoms | 1 | 0.02% |
| Menstrual discomfort | 1 | 0.02% |
| Menstrual disorder | 14 | 0.22% |
| Menstruation delayed | 1 | 0.02% |
| Menstruation irregular | 9 | 0.14% |
| Mental disorder | 3 | 0.05% |
| Mental impairment | 17 | 0.27% |
| Mental status changes | 31 | 0.49% |
| Mesenteric haemorrhage | 2 | 0.03% |
| Mesenteric vein thrombosis | 1 | 0.02% |
| Metabolic acidosis | 2 | 0.03% |
| Metabolic encephalopathy | 3 | 0.05% |
| Metabolic function test | 226 | 3.54% |
| Metabolic function test abnormal | 5 | 0.08% |
| Metabolic function test normal | 33 | 0.52% |
| Metabolic syndrome | 1 | 0.02% |
| Metamorphopsia | 6 | 0.09% |
| Metamyelocyte percentage increased | 1 | 0.02% |
| Metastases to liver | 1 | 0.02% |
| Microangiopathic haemolytic anaemia | 1 | 0.02% |
| Microbiology test | 1 | 0.02% |
| Microvascular coronary artery disease | 1 | 0.02% |
| Microvascular cranial nerve palsy | 1 | 0.02% |
| Micturition urgency | 2 | 0.03% |
| Middle ear effusion | 1 | 0.02% |
| Migraine | 147 | 2.3% |
| Migraine with aura | 1 | 0.02% |
| Migraine without aura | 1 | 0.02% |
| Miliaria | 5 | 0.08% |
| Miller Fisher syndrome | 2 | 0.03% |
| Mineral supplementation | 2 | 0.03% |
| Miosis | 2 | 0.03% |
| Mitral valve incompetence | 4 | 0.06% |
| Moaning | 4 | 0.06% |
| Mobility decreased | 100 | 1.57% |
| Monocyte count | 5 | 0.08% |
| Monocyte count decreased | 3 | 0.05% |
| Monocyte count increased | 15 | 0.24% |
| Monocyte count normal | 14 | 0.22% |
| Monocyte percentage | 16 | 0.25% |
| Monocyte percentage increased | 7 | 0.11% |
| Monocytosis | 1 | 0.02% |
| Mononucleosis heterophile test | 2 | 0.03% |
| Mononucleosis heterophile test negative | 2 | 0.03% |
| Mononucleosis heterophile test positive | 2 | 0.03% |
| Monoparesis | 1 | 0.02% |
| Monoplegia | 14 | 0.22% |
| Mood altered | 3 | 0.05% |
| Motion sickness | 3 | 0.05% |
| Motor dysfunction | 10 | 0.16% |
| Mouth haemorrhage | 4 | 0.06% |
| Mouth swelling | 11 | 0.17% |
| Mouth ulceration | 5 | 0.08% |
| Movement disorder | 37 | 0.58% |
| Mucosal discolouration | 1 | 0.02% |
| Mucosal disorder | 2 | 0.03% |
| Mucosal dryness | 1 | 0.02% |
| Mucosal haemorrhage | 1 | 0.02% |
| Mucous stools | 1 | 0.02% |
| Multifocal motor neuropathy | 1 | 0.02% |
| Multipathogen PCR test | 1 | 0.02% |
| Multiple allergies | 1 | 0.02% |
| Multiple organ dysfunction syndrome | 6 | 0.09% |
| Multiple sclerosis | 1 | 0.02% |
| Muscle atrophy | 1 | 0.02% |
| Muscle contractions involuntary | 6 | 0.09% |
| Muscle contracture | 6 | 0.09% |
| Muscle discomfort | 1 | 0.02% |
| Muscle disorder | 2 | 0.03% |
| Muscle fatigue | 5 | 0.08% |
| Muscle injury | 1 | 0.02% |
| Muscle oedema | 1 | 0.02% |
| Muscle rigidity | 10 | 0.16% |
| Muscle spasms | 174 | 2.73% |
| Muscle strain | 10 | 0.16% |
| Muscle strength abnormal | 2 | 0.03% |
| Muscle swelling | 2 | 0.03% |
| Muscle tightness | 32 | 0.5% |
| Muscle twitching | 40 | 0.63% |
| Muscular weakness | 144 | 2.26% |
| Musculoskeletal chest pain | 25 | 0.39% |
| Musculoskeletal discomfort | 14 | 0.22% |
| Musculoskeletal disorder | 4 | 0.06% |
| Musculoskeletal injury | 1 | 0.02% |
| Musculoskeletal pain | 11 | 0.17% |
| Musculoskeletal stiffness | 67 | 1.05% |
| Myalgia | 261 | 4.09% |
| Myasthenia gravis | 3 | 0.05% |
| Myasthenia gravis crisis | 1 | 0.02% |
| Mycobacterium tuberculosis complex test | 2 | 0.03% |
| Mycobacterium tuberculosis complex test negative | 1 | 0.02% |
| Mycoplasma test | 1 | 0.02% |
| Mydriasis | 9 | 0.14% |
| Myelitis transverse | 7 | 0.11% |
| Myelomalacia | 1 | 0.02% |
| Myelopathy | 1 | 0.02% |
| Myocardial fibrosis | 1 | 0.02% |
| Myocardial infarction | 35 | 0.55% |
| Myocardial ischaemia | 3 | 0.05% |
| Myocardial necrosis marker | 6 | 0.09% |
| Myocardial necrosis marker increased | 5 | 0.08% |
| Myocardial necrosis marker normal | 9 | 0.14% |
| Myocardial strain | 7 | 0.11% |
| Myocarditis | 11 | 0.17% |
| Myoclonus | 1 | 0.02% |
| Myoglobin blood | 1 | 0.02% |
| Myoglobin blood increased | 1 | 0.02% |
| Myositis | 1 | 0.02% |
| N-terminal prohormone brain natriuretic peptide | 6 | 0.09% |
| N-terminal prohormone brain natriuretic peptide increased | 4 | 0.06% |
| Nail bed disorder | 1 | 0.02% |
| Nail discolouration | 1 | 0.02% |
| Nasal cavity packing | 1 | 0.02% |
| Nasal congestion | 25 | 0.39% |
| Nasal discomfort | 3 | 0.05% |
| Nasal inflammation | 1 | 0.02% |
| Nasal injury | 3 | 0.05% |
| Nasal oedema | 2 | 0.03% |
| Nasoendoscopy | 3 | 0.05% |
| Nasopharyngitis | 18 | 0.28% |
| Nausea | 826 | 12.94% |
| Near death experience | 1 | 0.02% |
| Neck injury | 4 | 0.06% |
| Neck mass | 3 | 0.05% |
| Neck pain | 140 | 2.19% |
| Necrosis | 1 | 0.02% |
| Needle issue | 1 | 0.02% |
| Negative thoughts | 1 | 0.02% |
| Neisseria test | 1 | 0.02% |
| Nephritis | 1 | 0.02% |
| Nephrolithiasis | 9 | 0.14% |
| Nerve block | 2 | 0.03% |
| Nerve compression | 3 | 0.05% |
| Nerve conduction studies | 6 | 0.09% |
| Nerve injury | 7 | 0.11% |
| Nerve stimulation test abnormal | 1 | 0.02% |
| Nerve stimulation test normal | 1 | 0.02% |
| Nervousness | 32 | 0.5% |
| Nervous system disorder | 9 | 0.14% |
| Neuralgia | 36 | 0.56% |
| Neuritis | 3 | 0.05% |
| Neuro-ophthalmological test | 1 | 0.02% |
| Neurodevelopment test | 1 | 0.02% |
| Neurological examination | 16 | 0.25% |
| Neurological examination abnormal | 5 | 0.08% |
| Neurological examination normal | 3 | 0.05% |
| Neurological symptom | 33 | 0.52% |
| Neuromyelitis optica spectrum disorder | 1 | 0.02% |
| Neuropathy peripheral | 18 | 0.28% |
| Neutralising antibodies | 1 | 0.02% |
| Neutropenia | 1 | 0.02% |
| Neutrophil count | 10 | 0.16% |
| Neutrophil count decreased | 6 | 0.09% |
| Neutrophil count increased | 6 | 0.09% |
| Neutrophil count normal | 13 | 0.2% |
| Neutrophilia | 3 | 0.05% |
| Neutrophil percentage | 11 | 0.17% |
| Neutrophil percentage decreased | 6 | 0.09% |
| Neutrophil percentage increased | 11 | 0.17% |
| New daily persistent headache | 1 | 0.02% |
| Nightmare | 5 | 0.08% |
| Night sweats | 23 | 0.36% |
| NIH stroke scale | 1 | 0.02% |
| NIH stroke scale score increased | 3 | 0.05% |
| Nitrite urine | 1 | 0.02% |
| Nitrite urine absent | 7 | 0.11% |
| Nitrite urine present | 2 | 0.03% |
| No adverse event | 1 | 0.02% |
| Nodule | 14 | 0.22% |
| Non-cardiac chest pain | 1 | 0.02% |
| Non-high-density lipoprotein cholesterol | 1 | 0.02% |
| Noninfective encephalitis | 1 | 0.02% |
| Nonspecific reaction | 2 | 0.03% |
| Normochromic anaemia | 1 | 0.02% |
| Nucleated red cells | 5 | 0.08% |
| Nucleic acid test | 1 | 0.02% |
| Numb chin syndrome | 1 | 0.02% |
| Nystagmus | 1 | 0.02% |
| Obstructive airways disorder | 5 | 0.08% |
| Occult blood | 2 | 0.03% |
| Occult blood negative | 1 | 0.02% |
| Occult blood positive | 2 | 0.03% |
| Ocular discomfort | 21 | 0.33% |
| Ocular hyperaemia | 11 | 0.17% |
| Odynophagia | 1 | 0.02% |
| Oedema | 10 | 0.16% |
| Oedema peripheral | 33 | 0.52% |
| Oesophageal discomfort | 1 | 0.02% |
| Oesophageal disorder | 2 | 0.03% |
| Oesophageal rupture | 1 | 0.02% |
| Oesophageal spasm | 1 | 0.02% |
| Oesophageal stenosis | 1 | 0.02% |
| Oesophagitis | 2 | 0.03% |
| Oesophagogastroduodenoscopy | 1 | 0.02% |
| Office visit | 1 | 0.02% |
| Off label use | 3 | 0.05% |
| Oligomenorrhoea | 5 | 0.08% |
| Oliguria | 1 | 0.02% |
| On and off phenomenon | 5 | 0.08% |
| Open reduction of fracture | 1 | 0.02% |
| Ophthalmic migraine | 1 | 0.02% |
| Ophthalmic scan | 2 | 0.03% |
| Ophthalmological examination | 10 | 0.16% |
| Ophthalmological examination abnormal | 3 | 0.05% |
| Ophthalmological examination normal | 3 | 0.05% |
| Ophthalmoplegia | 1 | 0.02% |
| Opisthotonus | 1 | 0.02% |
| Optic ischaemic neuropathy | 2 | 0.03% |
| Optic nerve cupping | 1 | 0.02% |
| Optic nerve disorder | 4 | 0.06% |
| Optic neuritis | 6 | 0.09% |
| Oral blood blister | 1 | 0.02% |
| Oral candidiasis | 2 | 0.03% |
| Oral discomfort | 2 | 0.03% |
| Oral disorder | 1 | 0.02% |
| Oral herpes | 4 | 0.06% |
| Oral mucosal blistering | 2 | 0.03% |
| Oral mucosal eruption | 1 | 0.02% |
| Oral pain | 5 | 0.08% |
| Oral pruritus | 2 | 0.03% |
| Oral surgery | 1 | 0.02% |
| Oral viral infection | 1 | 0.02% |
| Organ failure | 1 | 0.02% |
| Oropharyngeal discomfort | 18 | 0.28% |
| Oropharyngeal oedema | 1 | 0.02% |
| Oropharyngeal pain | 93 | 1.46% |
| Orthopnoea | 1 | 0.02% |
| Orthostatic hypotension | 6 | 0.09% |
| Oscillopsia | 1 | 0.02% |
| Osteitis | 1 | 0.02% |
| Osteoarthritis | 3 | 0.05% |
| Osteonecrosis | 1 | 0.02% |
| Otitis externa | 1 | 0.02% |
| Otorrhoea | 1 | 0.02% |
| Otoscopy normal | 1 | 0.02% |
| Ovarian cyst | 3 | 0.05% |
| Ovarian cyst ruptured | 1 | 0.02% |
| Ovarian vein thrombosis | 1 | 0.02% |
| Overdose | 2 | 0.03% |
| Oxygen consumption decreased | 1 | 0.02% |
| Oxygen saturation | 34 | 0.53% |
| Oxygen saturation decreased | 30 | 0.47% |
| Oxygen saturation increased | 1 | 0.02% |
| Oxygen saturation normal | 1 | 0.02% |
| Oxygen therapy | 2 | 0.03% |
| Packed red blood cell transfusion | 2 | 0.03% |
| Pain | 781 | 12.24% |
| Pain assessment | 10 | 0.16% |
| Painful respiration | 29 | 0.45% |
| Pain in extremity | 801 | 12.55% |
| Pain in jaw | 29 | 0.45% |
| Pain of skin | 20 | 0.31% |
| Pallor | 165 | 2.59% |
| Palpable purpura | 2 | 0.03% |
| Palpitations | 222 | 3.48% |
| Pancreatic enzymes increased | 2 | 0.03% |
| Pancreatitis | 1 | 0.02% |
| Pancreatitis acute | 5 | 0.08% |
| Pancytopenia | 1 | 0.02% |
| Panic attack | 33 | 0.52% |
| Panic disorder | 1 | 0.02% |
| Panic reaction | 6 | 0.09% |
| Papillitis | 1 | 0.02% |
| Papilloedema | 2 | 0.03% |
| Paracentesis | 1 | 0.02% |
| Paraesthesia | 413 | 6.47% |
| Paraesthesia oral | 61 | 0.96% |
| Paralysis | 14 | 0.22% |
| Paranasal sinus discomfort | 12 | 0.19% |
| Paranoia | 1 | 0.02% |
| Parasite blood test | 1 | 0.02% |
| Paresis | 1 | 0.02% |
| Parosmia | 13 | 0.2% |
| Partial seizures | 1 | 0.02% |
| Pathology test | 6 | 0.09% |
| PCO2 | 1 | 0.02% |
| PCO2 decreased | 1 | 0.02% |
| PCO2 increased | 1 | 0.02% |
| Peak expiratory flow rate decreased | 1 | 0.02% |
| Pelvic pain | 8 | 0.13% |
| Pelvic venous thrombosis | 1 | 0.02% |
| Pemphigoid | 1 | 0.02% |
| Penile oedema | 1 | 0.02% |
| Penile rash | 1 | 0.02% |
| Peptic ulcer | 1 | 0.02% |
| Percutaneous coronary intervention | 2 | 0.03% |
| Perforated ulcer | 1 | 0.02% |
| Perfusion brain scan | 1 | 0.02% |
| Perfusion brain scan abnormal | 2 | 0.03% |
| Perfusion brain scan normal | 2 | 0.03% |
| Pericardial drainage | 1 | 0.02% |
| Pericardial effusion | 12 | 0.19% |
| Pericardial excision | 1 | 0.02% |
| Pericarditis | 21 | 0.33% |
| Perineal pain | 1 | 0.02% |
| Periodontitis | 1 | 0.02% |
| Periorbital cellulitis | 1 | 0.02% |
| Periorbital oedema | 1 | 0.02% |
| Periorbital pain | 1 | 0.02% |
| Periorbital swelling | 10 | 0.16% |
| Peripheral arterial occlusive disease | 2 | 0.03% |
| Peripheral artery occlusion | 3 | 0.05% |
| Peripheral artery stenosis | 1 | 0.02% |
| Peripheral artery thrombosis | 4 | 0.06% |
| Peripheral coldness | 31 | 0.49% |
| Peripheral embolism | 7 | 0.11% |
| Peripheral ischaemia | 3 | 0.05% |
| Peripheral swelling | 281 | 4.4% |
| Peripheral vascular disorder | 3 | 0.05% |
| Peripheral vein occlusion | 2 | 0.03% |
| Peripheral vein thrombus extension | 2 | 0.03% |
| Peripheral venous disease | 3 | 0.05% |
| Peritonsillar abscess | 1 | 0.02% |
| Peroneal nerve palsy | 1 | 0.02% |
| Personality change | 1 | 0.02% |
| Petechiae | 40 | 0.63% |
| Petit mal epilepsy | 4 | 0.06% |
| Phantom limb syndrome | 1 | 0.02% |
| Pharyngeal erythema | 1 | 0.02% |
| Pharyngeal hypoaesthesia | 6 | 0.09% |
| Pharyngeal inflammation | 1 | 0.02% |
| Pharyngeal oedema | 1 | 0.02% |
| Pharyngeal paraesthesia | 12 | 0.19% |
| Pharyngeal swelling | 96 | 1.5% |
| Pharyngeal ulceration | 1 | 0.02% |
| Pharyngitis | 5 | 0.08% |
| pH body fluid abnormal | 1 | 0.02% |
| Phlebitis | 1 | 0.02% |
| Phlebitis superficial | 1 | 0.02% |
| Phlebotomy | 1 | 0.02% |
| Phobia of driving | 1 | 0.02% |
| Photophobia | 29 | 0.45% |
| Photopsia | 9 | 0.14% |
| Photosensitivity reaction | 2 | 0.03% |
| pH urine | 1 | 0.02% |
| pH urine normal | 7 | 0.11% |
| Physical deconditioning | 1 | 0.02% |
| Physical disability | 1 | 0.02% |
| Physical examination | 12 | 0.19% |
| Physiotherapy | 1 | 0.02% |
| Piloerection | 1 | 0.02% |
| Pituitary tumour benign | 1 | 0.02% |
| Pityriasis rosea | 1 | 0.02% |
| Placental disorder | 1 | 0.02% |
| Plasmapheresis | 8 | 0.13% |
| Platelet count | 49 | 0.77% |
| Platelet count abnormal | 1 | 0.02% |
| Platelet count decreased | 87 | 1.36% |
| Platelet count increased | 13 | 0.2% |
| Platelet count normal | 105 | 1.65% |
| Platelet destruction increased | 1 | 0.02% |
| Platelet disorder | 2 | 0.03% |
| Platelet factor 4 | 2 | 0.03% |
| Platelet factor 4 decreased | 1 | 0.02% |
| Platelet factor 4 increased | 1 | 0.02% |
| Platelet morphology | 1 | 0.02% |
| Platelet morphology normal | 1 | 0.02% |
| Platelet storage pool deficiency | 1 | 0.02% |
| Platelet transfusion | 10 | 0.16% |
| Pleocytosis | 1 | 0.02% |
| Pleural effusion | 15 | 0.24% |
| Pleural thickening | 1 | 0.02% |
| Pleurisy | 4 | 0.06% |
| Pleuritic pain | 10 | 0.16% |
| Pneumococcal infection | 1 | 0.02% |
| Pneumonia | 66 | 1.03% |
| Pneumonia aspiration | 1 | 0.02% |
| Pneumonia pseudomonal | 1 | 0.02% |
| Pneumonitis | 5 | 0.08% |
| Pneumothorax | 4 | 0.06% |
| Pneumothorax traumatic | 1 | 0.02% |
| PO2 decreased | 1 | 0.02% |
| PO2 normal | 1 | 0.02% |
| Pollakiuria | 6 | 0.09% |
| Polyarthritis | 1 | 0.02% |
| Polychromic red blood cells present | 1 | 0.02% |
| Polycythaemia | 1 | 0.02% |
| Polydipsia | 1 | 0.02% |
| Polymenorrhagia | 1 | 0.02% |
| Polymenorrhoea | 2 | 0.03% |
| Polymerase chain reaction | 3 | 0.05% |
| Polyp | 1 | 0.02% |
| Polyuria | 3 | 0.05% |
| Poor peripheral circulation | 4 | 0.06% |
| Poor quality sleep | 8 | 0.13% |
| Portal vein thrombosis | 7 | 0.11% |
| Portosplenomesenteric venous thrombosis | 1 | 0.02% |
| Positron emission tomogram | 4 | 0.06% |
| Positron emission tomogram abnormal | 1 | 0.02% |
| Positron emission tomogram normal | 1 | 0.02% |
| Post-traumatic stress disorder | 1 | 0.02% |
| Post concussion syndrome | 1 | 0.02% |
| Posterior reversible encephalopathy syndrome | 2 | 0.03% |
| Postictal state | 1 | 0.02% |
| Post lumbar puncture syndrome | 1 | 0.02% |
| Postmenopausal haemorrhage | 2 | 0.03% |
| Post procedural complication | 1 | 0.02% |
| Post procedural haemorrhage | 1 | 0.02% |
| Postural orthostatic tachycardia syndrome | 4 | 0.06% |
| Posture abnormal | 14 | 0.22% |
| Posturing | 1 | 0.02% |
| Post vaccination syndrome | 1 | 0.02% |
| Pre-eclampsia | 1 | 0.02% |
| Pregnancy | 6 | 0.09% |
| Pregnancy test | 14 | 0.22% |
| Pregnancy test negative | 4 | 0.06% |
| Pregnancy test positive | 3 | 0.05% |
| Pregnancy test urine | 4 | 0.06% |
| Pregnancy test urine negative | 4 | 0.06% |
| Premature labour | 1 | 0.02% |
| Premature separation of placenta | 2 | 0.03% |
| Presyncope | 67 | 1.05% |
| Procalcitonin | 3 | 0.05% |
| Procalcitonin decreased | 1 | 0.02% |
| Procalcitonin increased | 3 | 0.05% |
| Product administered at inappropriate site | 3 | 0.05% |
| Product administered to patient of inappropriate age | 2 | 0.03% |
| Product administration error | 1 | 0.02% |
| Productive cough | 14 | 0.22% |
| Product storage error | 1 | 0.02% |
| Product use issue | 1 | 0.02% |
| Progressive multifocal leukoencephalopathy | 1 | 0.02% |
| Prophylaxis of nausea and vomiting | 1 | 0.02% |
| Prostate examination | 1 | 0.02% |
| Prostatic specific antigen decreased | 1 | 0.02% |
| Prostatitis | 1 | 0.02% |
| Protein C | 3 | 0.05% |
| Protein S | 3 | 0.05% |
| Protein S decreased | 1 | 0.02% |
| Protein total | 4 | 0.06% |
| Protein total decreased | 4 | 0.06% |
| Protein total increased | 4 | 0.06% |
| Protein total normal | 23 | 0.36% |
| Protein urine | 2 | 0.03% |
| Protein urine absent | 6 | 0.09% |
| Protein urine present | 4 | 0.06% |
| Prothrombin level | 2 | 0.03% |
| Prothrombin level increased | 1 | 0.02% |
| Prothrombin level normal | 1 | 0.02% |
| Prothrombin time | 29 | 0.45% |
| Prothrombin time normal | 13 | 0.2% |
| Prothrombin time prolonged | 11 | 0.17% |
| Prothrombin time shortened | 4 | 0.06% |
| Pruritus | 189 | 2.96% |
| Pruritus genital | 1 | 0.02% |
| Pseudohyponatraemia | 1 | 0.02% |
| Psoriasis | 1 | 0.02% |
| Psychiatric evaluation | 1 | 0.02% |
| Psychogenic seizure | 1 | 0.02% |
| Psychomotor hyperactivity | 2 | 0.03% |
| Psychomotor retardation | 1 | 0.02% |
| Psychotic behaviour | 1 | 0.02% |
| Psychotic disorder | 3 | 0.05% |
| Pulmonary arterial hypertension | 1 | 0.02% |
| Pulmonary arterial pressure abnormal | 2 | 0.03% |
| Pulmonary artery dilatation | 1 | 0.02% |
| Pulmonary artery thrombosis | 1 | 0.02% |
| Pulmonary congestion | 4 | 0.06% |
| Pulmonary embolism | 224 | 3.51% |
| Pulmonary fibrosis | 1 | 0.02% |
| Pulmonary function test | 5 | 0.08% |
| Pulmonary function test abnormal | 4 | 0.06% |
| Pulmonary function test decreased | 2 | 0.03% |
| Pulmonary function test normal | 2 | 0.03% |
| Pulmonary hypertension | 4 | 0.06% |
| Pulmonary imaging procedure | 1 | 0.02% |
| Pulmonary infarction | 9 | 0.14% |
| Pulmonary mass | 6 | 0.09% |
| Pulmonary oedema | 12 | 0.19% |
| Pulmonary pain | 11 | 0.17% |
| Pulmonary physical examination | 2 | 0.03% |
| Pulmonary thrombosis | 52 | 0.81% |
| Pulmonary vasculitis | 1 | 0.02% |
| Pulse abnormal | 9 | 0.14% |
| Pulse absent | 7 | 0.11% |
| Pulseless electrical activity | 1 | 0.02% |
| Pulse pressure increased | 1 | 0.02% |
| Pupil dilation procedure | 2 | 0.03% |
| Pupil fixed | 1 | 0.02% |
| Pupillary reflex impaired | 1 | 0.02% |
| Purpura | 10 | 0.16% |
| Pustule | 1 | 0.02% |
| Pyelonephritis acute | 1 | 0.02% |
| Pyrexia | 831 | 13.02% |
| QRS axis abnormal | 2 | 0.03% |
| Quality of life decreased | 3 | 0.05% |
| Radial nerve compression | 1 | 0.02% |
| Radial nerve injury | 1 | 0.02% |
| Radial nerve palsy | 1 | 0.02% |
| Radius fracture | 1 | 0.02% |
| Rales | 1 | 0.02% |
| Rash | 287 | 4.5% |
| Rash erythematous | 49 | 0.77% |
| Rash macular | 27 | 0.42% |
| Rash maculo-papular | 3 | 0.05% |
| Rash morbilliform | 1 | 0.02% |
| Rash papular | 10 | 0.16% |
| Rash pruritic | 44 | 0.69% |
| Rash vesicular | 3 | 0.05% |
| Raynaud's phenomenon | 1 | 0.02% |
| Reaction to previous exposure to any vaccine | 1 | 0.02% |
| Reading disorder | 2 | 0.03% |
| Rectal examination abnormal | 1 | 0.02% |
| Rectal haemorrhage | 5 | 0.08% |
| Red blood cell abnormality | 2 | 0.03% |
| Red blood cell count | 6 | 0.09% |
| Red blood cell count decreased | 18 | 0.28% |
| Red blood cell count increased | 6 | 0.09% |
| Red blood cell count normal | 22 | 0.34% |
| Red blood cell nucleated morphology | 6 | 0.09% |
| Red blood cell nucleated morphology present | 1 | 0.02% |
| Red blood cell sedimentation rate | 12 | 0.19% |
| Red blood cell sedimentation rate abnormal | 1 | 0.02% |
| Red blood cell sedimentation rate increased | 11 | 0.17% |
| Red blood cell sedimentation rate normal | 14 | 0.22% |
| Red blood cells urine | 1 | 0.02% |
| Red blood cells urine negative | 4 | 0.06% |
| Red blood cells urine positive | 2 | 0.03% |
| Red cell distribution width | 2 | 0.03% |
| Red cell distribution width decreased | 1 | 0.02% |
| Red cell distribution width increased | 10 | 0.16% |
| Red cell distribution width normal | 22 | 0.34% |
| Reduced facial expression | 1 | 0.02% |
| Reduction of increased intracranial pressure | 1 | 0.02% |
| Reflex test | 4 | 0.06% |
| Reflex test normal | 2 | 0.03% |
| Refusal of treatment by patient | 1 | 0.02% |
| Renal colic | 1 | 0.02% |
| Renal cyst | 1 | 0.02% |
| Renal disorder | 4 | 0.06% |
| Renal embolism | 1 | 0.02% |
| Renal failure | 5 | 0.08% |
| Renal function test | 1 | 0.02% |
| Renal function test abnormal | 2 | 0.03% |
| Renal function test normal | 7 | 0.11% |
| Renal haematoma | 1 | 0.02% |
| Renal impairment | 6 | 0.09% |
| Renal infarct | 4 | 0.06% |
| Renal pain | 14 | 0.22% |
| Renal replacement therapy | 1 | 0.02% |
| Respiration abnormal | 5 | 0.08% |
| Respiratory arrest | 8 | 0.13% |
| Respiratory disorder | 6 | 0.09% |
| Respiratory distress | 15 | 0.24% |
| Respiratory failure | 7 | 0.11% |
| Respiratory gas exchange disorder | 1 | 0.02% |
| Respiratory rate | 7 | 0.11% |
| Respiratory rate decreased | 2 | 0.03% |
| Respiratory rate increased | 16 | 0.25% |
| Respiratory symptom | 6 | 0.09% |
| Respiratory syncytial virus test | 2 | 0.03% |
| Respiratory syncytial virus test negative | 6 | 0.09% |
| Respiratory tract congestion | 26 | 0.41% |
| Respiratory tract irritation | 1 | 0.02% |
| Respiratory tract oedema | 2 | 0.03% |
| Respiratory viral panel | 8 | 0.13% |
| Respirovirus test positive | 1 | 0.02% |
| Restless legs syndrome | 3 | 0.05% |
| Restlessness | 10 | 0.16% |
| Resuscitation | 19 | 0.3% |
| Retching | 40 | 0.63% |
| Reticulocyte count | 2 | 0.03% |
| Retinal artery occlusion | 7 | 0.11% |
| Retinal detachment | 1 | 0.02% |
| Retinal function test abnormal | 1 | 0.02% |
| Retinal oedema | 1 | 0.02% |
| Retinal pallor | 1 | 0.02% |
| Retinal vascular thrombosis | 2 | 0.03% |
| Retinal vein occlusion | 3 | 0.05% |
| Retinitis pigmentosa | 1 | 0.02% |
| Retinogram | 1 | 0.02% |
| Retinopexy | 1 | 0.02% |
| Rhabdomyolysis | 4 | 0.06% |
| Rhesus antibodies | 1 | 0.02% |
| Rheumatoid arthritis | 1 | 0.02% |
| Rheumatoid factor | 3 | 0.05% |
| Rheumatoid factor negative | 4 | 0.06% |
| Rhinalgia | 5 | 0.08% |
| Rhinorrhoea | 29 | 0.45% |
| Rhinovirus infection | 1 | 0.02% |
| Rhonchi | 1 | 0.02% |
| Rib fracture | 3 | 0.05% |
| Right ventricular dilatation | 1 | 0.02% |
| Right ventricular dysfunction | 5 | 0.08% |
| Right ventricular enlargement | 3 | 0.05% |
| Right ventricular hypertrophy | 1 | 0.02% |
| Road traffic accident | 10 | 0.16% |
| Rotator cuff syndrome | 1 | 0.02% |
| Rotavirus test negative | 1 | 0.02% |
| Russell's viper venom time abnormal | 1 | 0.02% |
| Saline infusion sonogram | 2 | 0.03% |
| Salmonella test negative | 1 | 0.02% |
| Salpingectomy | 1 | 0.02% |
| Salpingitis | 1 | 0.02% |
| Sarcoidosis | 1 | 0.02% |
| SARS-CoV-2 antibody test | 6 | 0.09% |
| SARS-CoV-2 antibody test negative | 9 | 0.14% |
| SARS-CoV-2 antibody test positive | 5 | 0.08% |
| SARS-CoV-2 RNA | 1 | 0.02% |
| SARS-CoV-2 RNA undetectable | 1 | 0.02% |
| SARS-CoV-2 test | 129 | 2.02% |
| SARS-CoV-2 test negative | 181 | 2.84% |
| SARS-CoV-2 test positive | 118 | 1.85% |
| Scab | 3 | 0.05% |
| Scan | 16 | 0.25% |
| Scan abdomen abnormal | 2 | 0.03% |
| Scan abnormal | 5 | 0.08% |
| Scan brain | 6 | 0.09% |
| Scan myocardial perfusion | 2 | 0.03% |
| Scan myocardial perfusion abnormal | 1 | 0.02% |
| Scan normal | 2 | 0.03% |
| Scan spleen | 1 | 0.02% |
| Scan with contrast | 53 | 0.83% |
| Scan with contrast abnormal | 34 | 0.53% |
| Scan with contrast normal | 19 | 0.3% |
| Schistocytosis | 1 | 0.02% |
| Sciatica | 7 | 0.11% |
| Scintillating scotoma | 1 | 0.02% |
| Scleral discolouration | 1 | 0.02% |
| Scoliosis | 1 | 0.02% |
| Scratch | 1 | 0.02% |
| Screaming | 5 | 0.08% |
| Scrotal oedema | 1 | 0.02% |
| Seasonal allergy | 1 | 0.02% |
| Secretion discharge | 6 | 0.09% |
| Sedation | 1 | 0.02% |
| Seizure | 207 | 3.24% |
| Seizure like phenomena | 19 | 0.3% |
| Sensation of foreign body | 9 | 0.14% |
| Sensitive skin | 11 | 0.17% |
| Sensory disturbance | 25 | 0.39% |
| Sensory level abnormal | 1 | 0.02% |
| Sensory loss | 10 | 0.16% |
| Sensory overload | 1 | 0.02% |
| Sepsis | 10 | 0.16% |
| Sepsis syndrome | 1 | 0.02% |
| Septic screen | 1 | 0.02% |
| Septic shock | 6 | 0.09% |
| Serotonin syndrome | 2 | 0.03% |
| Serum ferritin | 1 | 0.02% |
| Serum ferritin normal | 1 | 0.02% |
| Serum serotonin | 1 | 0.02% |
| Sexual dysfunction | 1 | 0.02% |
| Sexually transmitted disease test | 1 | 0.02% |
| Shock | 5 | 0.08% |
| Shock haemorrhagic | 1 | 0.02% |
| Shoulder injury related to vaccine administration | 2 | 0.03% |
| Sickle cell anaemia with crisis | 1 | 0.02% |
| Single photon emission computerised tomogram | 1 | 0.02% |
| Sinonasal obstruction | 1 | 0.02% |
| Sinus bradycardia | 3 | 0.05% |
| Sinus congestion | 9 | 0.14% |
| Sinus disorder | 4 | 0.06% |
| Sinus headache | 2 | 0.03% |
| Sinusitis | 20 | 0.31% |
| Sinus node dysfunction | 1 | 0.02% |
| Sinus pain | 6 | 0.09% |
| Sinus rhythm | 4 | 0.06% |
| Sinus tachycardia | 23 | 0.36% |
| Sitting disability | 1 | 0.02% |
| Skin abrasion | 4 | 0.06% |
| Skin atrophy | 2 | 0.03% |
| Skin burning sensation | 31 | 0.49% |
| Skin culture | 1 | 0.02% |
| Skin discolouration | 50 | 0.78% |
| Skin discomfort | 1 | 0.02% |
| Skin disorder | 1 | 0.02% |
| Skin exfoliation | 6 | 0.09% |
| Skin fragility | 1 | 0.02% |
| Skin hyperpigmentation | 1 | 0.02% |
| Skin induration | 3 | 0.05% |
| Skin infection | 1 | 0.02% |
| Skin injury | 1 | 0.02% |
| Skin irritation | 5 | 0.08% |
| Skin laceration | 20 | 0.31% |
| Skin lesion | 6 | 0.09% |
| Skin mass | 5 | 0.08% |
| Skin odour abnormal | 1 | 0.02% |
| Skin reaction | 2 | 0.03% |
| Skin sensitisation | 4 | 0.06% |
| Skin swelling | 5 | 0.08% |
| Skin test negative | 1 | 0.02% |
| Skin tightness | 11 | 0.17% |
| Skin ulcer | 3 | 0.05% |
| Skin warm | 53 | 0.83% |
| Skin weeping | 1 | 0.02% |
| Skull fracture | 1 | 0.02% |
| Skull fractured base | 1 | 0.02% |
| Skull X-ray abnormal | 1 | 0.02% |
| Sleep deficit | 1 | 0.02% |
| Sleep disorder | 78 | 1.22% |
| Sleep study | 2 | 0.03% |
| Sleep talking | 1 | 0.02% |
| Slow response to stimuli | 3 | 0.05% |
| Slow speech | 8 | 0.13% |
| Sluggishness | 5 | 0.08% |
| Small cell lung cancer | 1 | 0.02% |
| Smear test | 2 | 0.03% |
| Sneezing | 10 | 0.16% |
| Snoring | 3 | 0.05% |
| Soft tissue inflammation | 1 | 0.02% |
| Soft tissue injury | 1 | 0.02% |
| Soft tissue necrosis | 1 | 0.02% |
| Somatotropin stimulation test | 1 | 0.02% |
| Somnolence | 69 | 1.08% |
| Specific gravity urine | 1 | 0.02% |
| Specific gravity urine increased | 2 | 0.03% |
| Specific gravity urine normal | 4 | 0.06% |
| Speech disorder | 54 | 0.85% |
| Speech disorder developmental | 1 | 0.02% |
| Speech rehabilitation | 1 | 0.02% |
| Spider vein | 1 | 0.02% |
| Spinal cord abscess | 1 | 0.02% |
| Spinal cord disorder | 2 | 0.03% |
| Spinal cord infarction | 1 | 0.02% |
| Spinal cord injury cervical | 1 | 0.02% |
| Spinal fracture | 1 | 0.02% |
| Spinal laminectomy | 1 | 0.02% |
| Spinal myelogram normal | 1 | 0.02% |
| Spinal osteoarthritis | 2 | 0.03% |
| Spinal pain | 18 | 0.28% |
| Spinal stenosis | 2 | 0.03% |
| Spinal X-ray | 11 | 0.17% |
| Spinal X-ray normal | 3 | 0.05% |
| Spirometry | 1 | 0.02% |
| Splenectomy | 1 | 0.02% |
| Splenic artery thrombosis | 1 | 0.02% |
| Splenic haemorrhage | 2 | 0.03% |
| Splenic infarction | 4 | 0.06% |
| Splenic rupture | 2 | 0.03% |
| Splenic thrombosis | 3 | 0.05% |
| Splenomegaly | 4 | 0.06% |
| Splinter haemorrhages | 1 | 0.02% |
| Spontaneous haemorrhage | 1 | 0.02% |
| Sputum abnormal | 1 | 0.02% |
| Sputum culture | 2 | 0.03% |
| Sputum discoloured | 2 | 0.03% |
| Staphylococcal infection | 2 | 0.03% |
| Staphylococcus test positive | 1 | 0.02% |
| Staring | 3 | 0.05% |
| Status asthmaticus | 1 | 0.02% |
| Status epilepticus | 1 | 0.02% |
| Stent placement | 9 | 0.14% |
| Steroid diabetes | 1 | 0.02% |
| Sticky skin | 1 | 0.02% |
| Stiff leg syndrome | 1 | 0.02% |
| Stomatitis | 6 | 0.09% |
| Stool analysis | 3 | 0.05% |
| Strabismus | 1 | 0.02% |
| Streptococcal bacteraemia | 1 | 0.02% |
| Streptococcus test | 5 | 0.08% |
| Streptococcus test negative | 12 | 0.19% |
| Streptococcus test positive | 2 | 0.03% |
| Stress | 6 | 0.09% |
| Stress cardiomyopathy | 1 | 0.02% |
| Stress echocardiogram | 3 | 0.05% |
| Stridor | 1 | 0.02% |
| Subacute inflammatory demyelinating polyneuropathy | 1 | 0.02% |
| Subarachnoid haemorrhage | 11 | 0.17% |
| Subclavian vein thrombosis | 3 | 0.05% |
| Subdural haematoma | 9 | 0.14% |
| Subdural haematoma evacuation | 1 | 0.02% |
| Subdural haemorrhage | 2 | 0.03% |
| Substance use | 1 | 0.02% |
| Sudden death | 1 | 0.02% |
| Sudden hearing loss | 3 | 0.05% |
| Suffocation feeling | 3 | 0.05% |
| Suicidal ideation | 2 | 0.03% |
| Superior mesenteric artery syndrome | 1 | 0.02% |
| Superior sagittal sinus thrombosis | 3 | 0.05% |
| Supernumerary rib | 1 | 0.02% |
| Suppressed lactation | 1 | 0.02% |
| Supraventricular extrasystoles | 2 | 0.03% |
| Supraventricular tachycardia | 10 | 0.16% |
| Surgery | 21 | 0.33% |
| Suspected COVID-19 | 8 | 0.13% |
| Suspected product contamination | 1 | 0.02% |
| Suture insertion | 2 | 0.03% |
| Swelling | 78 | 1.22% |
| Swelling face | 101 | 1.58% |
| Swelling of eyelid | 8 | 0.13% |
| Swollen tongue | 70 | 1.1% |
| Syncope | 446 | 6.99% |
| Synovial cyst | 3 | 0.05% |
| Systemic inflammatory response syndrome | 3 | 0.05% |
| Systemic lupus erythematosus | 3 | 0.05% |
| T-lymphocyte count increased | 1 | 0.02% |
| Tachycardia | 111 | 1.74% |
| Tachyphrenia | 1 | 0.02% |
| Tachypnoea | 5 | 0.08% |
| Taste disorder | 18 | 0.28% |
| Tearfulness | 5 | 0.08% |
| Temperature difference of extremities | 1 | 0.02% |
| Temperature intolerance | 4 | 0.06% |
| Temperature regulation disorder | 1 | 0.02% |
| Tenderness | 35 | 0.55% |
| Tendonitis | 1 | 0.02% |
| Tendon pain | 3 | 0.05% |
| Tendon rupture | 1 | 0.02% |
| Tension | 5 | 0.08% |
| Tension headache | 6 | 0.09% |
| Testicular pain | 4 | 0.06% |
| Testicular swelling | 1 | 0.02% |
| Thalamic infarction | 1 | 0.02% |
| Therapeutic product effect decreased | 1 | 0.02% |
| Therapeutic response unexpected | 1 | 0.02% |
| Therapy non-responder | 2 | 0.03% |
| Thinking abnormal | 5 | 0.08% |
| Third stage postpartum haemorrhage | 1 | 0.02% |
| Third trimester pregnancy | 1 | 0.02% |
| Thirst | 23 | 0.36% |
| Thoracic operation | 2 | 0.03% |
| Throat clearing | 1 | 0.02% |
| Throat irritation | 59 | 0.92% |
| Throat tightness | 121 | 1.9% |
| Thrombectomy | 16 | 0.25% |
| Thrombin time | 1 | 0.02% |
| Thrombin time normal | 1 | 0.02% |
| Thrombocytopenia | 37 | 0.58% |
| Thrombocytopenic purpura | 2 | 0.03% |
| Thromboelastogram | 1 | 0.02% |
| Thromboembolectomy | 4 | 0.06% |
| Thrombolysis | 4 | 0.06% |
| Thrombophlebitis | 4 | 0.06% |
| Thrombophlebitis superficial | 25 | 0.39% |
| Thrombosis | 235 | 3.68% |
| Thrombotic cerebral infarction | 1 | 0.02% |
| Thrombotic microangiopathy | 1 | 0.02% |
| Thrombotic thrombocytopenic purpura | 4 | 0.06% |
| Thunderclap headache | 1 | 0.02% |
| Thyroid disorder | 1 | 0.02% |
| Thyroid function test | 4 | 0.06% |
| Thyroid function test abnormal | 2 | 0.03% |
| Thyroid function test normal | 6 | 0.09% |
| Thyroid hormones increased | 1 | 0.02% |
| Thyroiditis | 1 | 0.02% |
| Thyroxine | 1 | 0.02% |
| Thyroxine free | 3 | 0.05% |
| Thyroxine free normal | 3 | 0.05% |
| Thyroxine normal | 1 | 0.02% |
| Tilt table test | 1 | 0.02% |
| Tilt table test positive | 1 | 0.02% |
| Tinnitus | 93 | 1.46% |
| Tongue biting | 1 | 0.02% |
| Tongue blistering | 3 | 0.05% |
| Tongue coated | 1 | 0.02% |
| Tongue discolouration | 2 | 0.03% |
| Tongue discomfort | 4 | 0.06% |
| Tongue disorder | 6 | 0.09% |
| Tongue erythema | 2 | 0.03% |
| Tongue oedema | 2 | 0.03% |
| Tongue pruritus | 4 | 0.06% |
| Tongue ulceration | 1 | 0.02% |
| Tonic clonic movements | 6 | 0.09% |
| Tonsillar cyst | 1 | 0.02% |
| Tonsillar inflammation | 1 | 0.02% |
| Tonsillitis | 1 | 0.02% |
| Tonsillolith | 1 | 0.02% |
| Toothache | 8 | 0.13% |
| Tooth disorder | 1 | 0.02% |
| Tooth fracture | 4 | 0.06% |
| Tooth injury | 3 | 0.05% |
| Tooth loss | 1 | 0.02% |
| Total complement activity test | 1 | 0.02% |
| Total lung capacity decreased | 1 | 0.02% |
| Toxicologic test | 1 | 0.02% |
| Toxicologic test abnormal | 1 | 0.02% |
| Toxicologic test normal | 1 | 0.02% |
| Toxoplasma serology | 1 | 0.02% |
| Toxoplasma serology negative | 1 | 0.02% |
| Tracheal disorder | 1 | 0.02% |
| Tracheobronchitis | 1 | 0.02% |
| Tracheostomy | 2 | 0.03% |
| Transaminases increased | 2 | 0.03% |
| Transcranial electrical motor evoked potential monitoring | 1 | 0.02% |
| Transcutaneous pacing | 1 | 0.02% |
| Transferrin saturation decreased | 1 | 0.02% |
| Transfusion | 11 | 0.17% |
| Transient global amnesia | 4 | 0.06% |
| Transient ischaemic attack | 35 | 0.55% |
| Transverse sinus stenosis | 1 | 0.02% |
| Transverse sinus thrombosis | 11 | 0.17% |
| Traumatic haemorrhage | 3 | 0.05% |
| Traumatic lung injury | 1 | 0.02% |
| Tremor | 253 | 3.96% |
| Treponema test | 1 | 0.02% |
| Treponema test negative | 7 | 0.11% |
| Trichoglossia | 1 | 0.02% |
| Tricuspid valve incompetence | 1 | 0.02% |
| Trigeminal nerve disorder | 1 | 0.02% |
| Trigeminal nerve injection | 1 | 0.02% |
| Trigeminal neuralgia | 5 | 0.08% |
| Trigger finger | 1 | 0.02% |
| Trismus | 5 | 0.08% |
| Troponin | 74 | 1.16% |
| Troponin I | 21 | 0.33% |
| Troponin I decreased | 1 | 0.02% |
| Troponin I increased | 4 | 0.06% |
| Troponin increased | 35 | 0.55% |
| Troponin I normal | 17 | 0.27% |
| Troponin normal | 33 | 0.52% |
| Troponin T | 6 | 0.09% |
| Troponin T increased | 2 | 0.03% |
| Troponin T normal | 2 | 0.03% |
| Trunk injury | 1 | 0.02% |
| Tryptase | 1 | 0.02% |
| Tuberculin test | 1 | 0.02% |
| Tuberous sclerosis complex | 1 | 0.02% |
| Tumefactive multiple sclerosis | 1 | 0.02% |
| Tunnel vision | 7 | 0.11% |
| Tympanometry abnormal | 1 | 0.02% |
| Type 1 diabetes mellitus | 1 | 0.02% |
| Type 2 diabetes mellitus | 3 | 0.05% |
| Type IV hypersensitivity reaction | 1 | 0.02% |
| Ulnar nerve palsy | 1 | 0.02% |
| Ultrasound abdomen | 22 | 0.34% |
| Ultrasound abdomen abnormal | 3 | 0.05% |
| Ultrasound abdomen normal | 8 | 0.13% |
| Ultrasound antenatal screen abnormal | 1 | 0.02% |
| Ultrasound biliary tract | 1 | 0.02% |
| Ultrasound biliary tract normal | 1 | 0.02% |
| Ultrasound breast | 1 | 0.02% |
| Ultrasound chest | 3 | 0.05% |
| Ultrasound Doppler | 104 | 1.63% |
| Ultrasound Doppler abnormal | 92 | 1.44% |
| Ultrasound Doppler normal | 46 | 0.72% |
| Ultrasound eye normal | 1 | 0.02% |
| Ultrasound kidney abnormal | 1 | 0.02% |
| Ultrasound pelvis | 4 | 0.06% |
| Ultrasound pelvis normal | 1 | 0.02% |
| Ultrasound scan | 219 | 3.43% |
| Ultrasound scan abnormal | 64 | 1% |
| Ultrasound scan normal | 63 | 0.99% |
| Ultrasound scan vagina | 7 | 0.11% |
| Ultrasound skull | 1 | 0.02% |
| Ultrasound thyroid abnormal | 1 | 0.02% |
| Ultrasound thyroid normal | 1 | 0.02% |
| Ultrasound uterus | 1 | 0.02% |
| Ultrasound uterus normal | 1 | 0.02% |
| Unevaluable event | 18 | 0.28% |
| Unresponsive to stimuli | 145 | 2.27% |
| Upper-airway cough syndrome | 2 | 0.03% |
| Upper motor neurone lesion | 1 | 0.02% |
| Upper respiratory tract congestion | 1 | 0.02% |
| Upper respiratory tract infection | 5 | 0.08% |
| Ureteroscopy | 1 | 0.02% |
| Urethral pain | 1 | 0.02% |
| Urinary bladder haemorrhage | 1 | 0.02% |
| Urinary casts | 1 | 0.02% |
| Urinary hesitation | 1 | 0.02% |
| Urinary incontinence | 28 | 0.44% |
| Urinary retention | 7 | 0.11% |
| Urinary sediment present | 2 | 0.03% |
| Urinary straining | 1 | 0.02% |
| Urinary system X-ray | 1 | 0.02% |
| Urinary tract infection | 28 | 0.44% |
| Urinary tract pain | 1 | 0.02% |
| Urine abnormality | 4 | 0.06% |
| Urine analysis | 193 | 3.02% |
| Urine analysis abnormal | 14 | 0.22% |
| Urine analysis normal | 42 | 0.66% |
| Urine electrolytes normal | 1 | 0.02% |
| Urine ketone body | 1 | 0.02% |
| Urine ketone body absent | 5 | 0.08% |
| Urine ketone body present | 4 | 0.06% |
| Urine leukocyte esterase | 7 | 0.11% |
| Urine leukocyte esterase positive | 1 | 0.02% |
| Urine output decreased | 2 | 0.03% |
| Urobilinogen urine | 3 | 0.05% |
| Urobilinogen urine decreased | 2 | 0.03% |
| Urobilinogen urine increased | 3 | 0.05% |
| Urogram normal | 1 | 0.02% |
| Urticaria | 208 | 3.26% |
| Urticaria chronic | 1 | 0.02% |
| Uterine contractions during pregnancy | 1 | 0.02% |
| Uterine cyst | 1 | 0.02% |
| Uterine dilation and curettage | 3 | 0.05% |
| Uterine haemorrhage | 1 | 0.02% |
| Uterine leiomyoma | 2 | 0.03% |
| Uterine polyp | 1 | 0.02% |
| Uterine spasm | 1 | 0.02% |
| Vaccination complication | 24 | 0.38% |
| Vaccination failure | 14 | 0.22% |
| Vaccination site inflammation | 1 | 0.02% |
| Vaccination site pain | 1 | 0.02% |
| Vaccination site swelling | 2 | 0.03% |
| Vaccination site warmth | 1 | 0.02% |
| Vaccine breakthrough infection | 2 | 0.03% |
| Vaccine positive rechallenge | 1 | 0.02% |
| Vaginal dilation procedure | 1 | 0.02% |
| Vaginal discharge | 2 | 0.03% |
| Vaginal haemorrhage | 16 | 0.25% |
| Vaginal lesion | 1 | 0.02% |
| Vaginal ulceration | 3 | 0.05% |
| Varicella virus test | 1 | 0.02% |
| Varicella virus test negative | 2 | 0.03% |
| Varicella virus test positive | 1 | 0.02% |
| Varicose vein | 4 | 0.06% |
| Vascular access site bruising | 1 | 0.02% |
| Vascular imaging | 1 | 0.02% |
| Vascular occlusion | 2 | 0.03% |
| Vascular pain | 2 | 0.03% |
| Vascular stent thrombosis | 1 | 0.02% |
| Vascular test | 1 | 0.02% |
| Vascular test normal | 1 | 0.02% |
| Vasculitis | 5 | 0.08% |
| Vasoconstriction | 1 | 0.02% |
| Vasodilatation | 10 | 0.16% |
| Vasogenic cerebral oedema | 1 | 0.02% |
| Vasopressive therapy | 1 | 0.02% |
| Vein discolouration | 2 | 0.03% |
| Vein disorder | 5 | 0.08% |
| Vein rupture | 1 | 0.02% |
| Vena cava filter insertion | 5 | 0.08% |
| Venogram | 14 | 0.22% |
| Venogram abnormal | 14 | 0.22% |
| Venogram normal | 15 | 0.24% |
| Venous angioplasty | 1 | 0.02% |
| Venous occlusion | 5 | 0.08% |
| Venous thrombosis | 2 | 0.03% |
| Venous thrombosis limb | 5 | 0.08% |
| Ventilation/perfusion scan | 6 | 0.09% |
| Ventilation/perfusion scan abnormal | 1 | 0.02% |
| Ventilation/perfusion scan normal | 1 | 0.02% |
| Ventricular arrhythmia | 1 | 0.02% |
| Ventricular assist device insertion | 1 | 0.02% |
| Ventricular drainage | 1 | 0.02% |
| Ventricular extrasystoles | 9 | 0.14% |
| Ventricular fibrillation | 3 | 0.05% |
| Ventricular hypertrophy | 1 | 0.02% |
| Ventricular hypokinesia | 2 | 0.03% |
| Ventricular remodelling | 1 | 0.02% |
| Ventricular septal defect | 1 | 0.02% |
| Ventricular tachycardia | 3 | 0.05% |
| Ventriculo-peritoneal shunt | 1 | 0.02% |
| Vertebral artery dissection | 3 | 0.05% |
| Vertebral artery hypoplasia | 1 | 0.02% |
| Vertebral artery occlusion | 1 | 0.02% |
| Vertebral artery stenosis | 1 | 0.02% |
| Vertebral artery thrombosis | 1 | 0.02% |
| Vertebral foraminal stenosis | 1 | 0.02% |
| Vertebral osteophyte | 1 | 0.02% |
| Vertigo | 113 | 1.77% |
| Vertigo positional | 4 | 0.06% |
| Very low density lipoprotein normal | 2 | 0.03% |
| Vestibular function test normal | 1 | 0.02% |
| Vestibular migraine | 1 | 0.02% |
| Vestibular neuronitis | 2 | 0.03% |
| Vibratory sense increased | 1 | 0.02% |
| Victim of abuse | 1 | 0.02% |
| Violence-related symptom | 1 | 0.02% |
| Viral infection | 5 | 0.08% |
| Viral myocarditis | 1 | 0.02% |
| Viral pericarditis | 1 | 0.02% |
| Viral rash | 1 | 0.02% |
| Viral sepsis | 1 | 0.02% |
| Viral test | 4 | 0.06% |
| Viral test negative | 8 | 0.13% |
| Viral titre | 1 | 0.02% |
| Visceral pain | 1 | 0.02% |
| Vision blurred | 204 | 3.2% |
| Visual acuity reduced | 3 | 0.05% |
| Visual acuity reduced transiently | 1 | 0.02% |
| Visual acuity tests | 1 | 0.02% |
| Visual acuity tests normal | 1 | 0.02% |
| Visual field defect | 14 | 0.22% |
| Visual impairment | 99 | 1.55% |
| Visual pathway disorder | 1 | 0.02% |
| Vital functions abnormal | 1 | 0.02% |
| Vital signs measurement | 64 | 1% |
| Vitamin A | 1 | 0.02% |
| Vitamin B6 normal | 1 | 0.02% |
| Vitamin B12 | 5 | 0.08% |
| Vitamin B12 decreased | 2 | 0.03% |
| Vitamin B12 deficiency | 1 | 0.02% |
| Vitamin B12 normal | 8 | 0.13% |
| Vitamin C | 1 | 0.02% |
| Vitamin D | 6 | 0.09% |
| Vitamin D decreased | 6 | 0.09% |
| Vitamin E | 1 | 0.02% |
| VIth nerve paralysis | 1 | 0.02% |
| Vitreous detachment | 2 | 0.03% |
| Vitreous floaters | 7 | 0.11% |
| Vocal cord paralysis | 1 | 0.02% |
| Vomiting | 460 | 7.21% |
| Vomiting projectile | 3 | 0.05% |
| Vulval disorder | 1 | 0.02% |
| Vulval ulceration | 1 | 0.02% |
| Walking aid user | 13 | 0.2% |
| Weight | 2 | 0.03% |
| Weight bearing difficulty | 6 | 0.09% |
| Weight decreased | 32 | 0.5% |
| Weight increased | 5 | 0.08% |
| West Nile virus test | 1 | 0.02% |
| Wheelchair user | 6 | 0.09% |
| Wheezing | 42 | 0.66% |
| White blood cell count | 14 | 0.22% |
| White blood cell count abnormal | 1 | 0.02% |
| White blood cell count decreased | 20 | 0.31% |
| White blood cell count increased | 57 | 0.89% |
| White blood cell count normal | 43 | 0.67% |
| White blood cell disorder | 1 | 0.02% |
| White blood cell scan | 1 | 0.02% |
| White blood cells urine negative | 5 | 0.08% |
| White blood cells urine positive | 3 | 0.05% |
| White matter lesion | 3 | 0.05% |
| Wisdom teeth removal | 1 | 0.02% |
| Withdrawal of life support | 2 | 0.03% |
| Withdrawal syndrome | 1 | 0.02% |
| Wound | 3 | 0.05% |
| Wound haemorrhage | 1 | 0.02% |
| Wrong technique in product usage process | 1 | 0.02% |
| X-ray | 150 | 2.35% |
| X-ray abnormal | 12 | 0.19% |
| X-ray gastrointestinal tract normal | 1 | 0.02% |
| X-ray limb | 11 | 0.17% |
| X-ray limb abnormal | 3 | 0.05% |
| X-ray limb normal | 5 | 0.08% |
| X-ray normal | 30 | 0.47% |
| X-ray of pelvis and hip | 2 | 0.03% |
| X-ray of pelvis and hip abnormal | 1 | 0.02% |
| X-ray of pelvis and hip normal | 1 | 0.02% |
| X-ray therapy to blood | 1 | 0.02% |
| Yawning | 1 | 0.02% |
| Yellow skin | 2 | 0.03% |
| TOTAL | † 45,467 | † 712.43% |
| † Because some cases have multiple vaccinations and symptoms, a single case can account for multiple entries in this table. This is the reason why the Total Count is greater than 6382 (the number of cases found), and the Total Percentage is greater than 100. | ||
| Case Details |
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: Immediate burning in both arms. Unable to hold a pencil to fill out card after receiving vaccine. Weakness in upper extremities. Tingling, pain and numbness in both arms, red streaks appeared on the left arm going further up on to the shoulder, the were visible and painful for about 90 mins. Sweating. Nausea. Blurred vision. Loss of consciousness. Headache behind the eyes. | ||||||||||||||||
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: Dizziness, lightheadedness, chest pain, increased respiration, gagging | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: (3) syncopal episodes following vaccination, one of which resulted in a fall with direct injury to the base of neck, head, and right flank. Pt reported chest pain prior to syncope. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Patient was being monitored for 30 minutes by EMS due to anaphylaxis to Shrimp. About 15 minutes into monitoring, the patient reported to EMS that he was feeling sweaty and had some shortness of breath. EMS reported BP to be 171/89 and pulse of 88. Patient stated that he does take blood pressure medication and reported that BP was elevated for him. EMS contacted ambulance for transport to Emergency room, patient in agreement to transport. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: 14:59 - RN responded to waiting lot. Pt c/o sensation of facial swelling and heart racing. Denied other complaints. At 1500 BP 110/80, HR 140, R 12. 1503: Pt helt HR slowing down. No further feeling of swelling in face, throat, or elsewhere. 1505: HR 128. 1510: Pt talking, breathing without difficulty. Advised to seek medical attention if s/sx worsen. 3/5/21 @ 1040: Another RN followed up with ph call. Pt reported that after leaving site, she felt HR beginning to speed up. Went to ED and was monitored x 2 hrs. Systolic pressure there was 161. HR was in 140''s. No interventions. After 2 hrs VS stabilized and pt was discharged home. Is fine today. | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: 65m received J&J vaccine, 10 minutes after admit c/o a gripping pain mid sternum, a 2 on scale of 1-10. Pt brought ot observation area, pain non changing after 15 minutes, eval''d by on site EMS. Transferred to ED for eval. Pt notified his daughter prior to leaving vaccine clinic. He had no complaints of other symptoms. Per electronic health records, pt drove himself to ED. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Pt was released after 15 min of monitoring. As soon as pt got in her car 9Parking lot is 3 minutes away from vaccination site) Pt developed palpitations (HR:156/min) Pt drove to the ER (3 blocks away from parking lot) Pt is currently in the ER, HR between 107-119. | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: Patient had sudden onset of sensation of palpations and light headedness "lasting one second" in middle of night on the day after receipt of COVID-19 vaccine. Felt urgent need for medical treatment & came to our ER. Has had similar episodes previously that have been partly diagnosed as anxiety though without light-headedness. Vitals in ER HR 141, BP 147/101. Believed to be sinus tachycardia. Has been prescribed venlafaxine, lorazepam, and metoprolol previously for this. Has seen cardiologist but per patient no specific diagnosis. As yet, patient has received a fluid bolus in ER. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Patient c/o throat closing, SOB, and chest pain within minutes after receiving the vaccine. Her vital signs showed tachycardia, increased respirations, and elevated blood pressure. She had a hard time speaking in full sentences. She does have a history of anaphylaxis to certain medications. She was administered epinephrine auto injector IM and brought to the emergency department by rapid response team. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Pt was held for 15 minutes. Past 15 minutes, patient was ready to leave but complained of nausea. Asked pt to stick around. Took blood pressure. It was low ~90/55. Asked again how he was doing, stated okay but feeling chills/cold. Started to shake uncontrollably. Ask pt if he thought a hospital visit was necessary; he stated no at that time. Decision was made to call squad; BP was elevated now and still shaking. Transported at that time. | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: pt had elevated blood pressure that persisted. bp 20/114 and repeat 5 min later 232/126 | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: Pt developed a rash on her finger that spread to her wrist. Benadryl 25mg was given.. the rash improved. Pt blood pressure elevated 195/113, repeat 207/117. Pt developed nausea and abdominal pain. Pt was transported to the ER | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: body aches, back pain, vomiting | ||||||||||||||||
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: Systemic: Fainting / Unresponsive-Mild, Systemic: Patient passed out and recovery after 40 seconds of chest compression-Mild, Additional Details: Patient was seen rocking back and forth in his chair according to 3 observers in the room, then fell back hit his head after observed his face turned pale. 3 Observers rushed over to him, patient was not breathing, unconscious and not responsive, eye ball stiff, sweating but cold. Eyelid peeled back and the eye is responsive to light. Started chest compression immediately and after 40 seconds of chest compression at third round, patient came back. no hx of preexisting condition or allergies note | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Medium, Systemic: Hyperventilation-Medium, Systemic: Nausea-Mild, Systemic: Shakiness-Medium, Additional Details: Patient felt faint immediately upon receiving the vaccination. received instruction to sit down. upon sitting down patient passed out/fainted/ muscle contractions in both hands were observed. 911 emergency services were contacted. patient then taken into ambulance for further evaluation. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Fever of 104, heart rate in 160''s, rigor, severe back pain. 911 called and ambulance brought to Hospital at 1am. Took 3 bags of fluids, Ativan, Tylenol and Toradol to get the heart to the 110''s over the 3 hours there. It is now 12:30 on the following day (3/7) and the fever, shakes, and elevated heart is starting up again but not to the extreme of last night | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Individual responded to waiting parking lot. Patient c/o sensation of facial swelling and heart racing. Denied other complaints. 1500 B/P 110/80. HR 140 Resp 12. 1503 Pt states she felt heart rate slowing down. No further feeling of swelling in face, throat, or elsewhere. 1505 HR 128. 1510 Patient talking and breathing without difficulty. Advised to seek medical attention if s/s worsen. 3/5/2021 @ 1040 employee f/u with patient with phone call. Patient reported that after leaving the site, she felt HR increasing. Went to ED and was monitored for two hours. Systolic pressure there was 161. HR was in 140s. No interventions by ED after monitor. States is fine today. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: I received the vaccine at a Department of Health vaccine clinic at the Hospital. About 25 minutes after receiving the Janssen vaccine, my face became flushed (red) and I felt weak. We were in the hospital parking lot and drove to that hospital''s emergency room, where I was evaluated. After several tests (item 18) I was declared okay and left after 3 hours with no further intervention. I probably should have taken a Benadryl (diphenhydramine) after the shot to prevent such a reaction. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: heart palpatation | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: itching, hives, redness, dizzy | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: DEVELOPED SWOLLEN THROAT GLANDS, SORE THROAT, SWOLLEN FACE, KNOT UNDER CHIN, PAIN AROUND NECK | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: 7:30pm unusual restlessness in both legs; by 8:30pm dull constant pain increased, legs were weak, knees wobbly, hands shaking. Pain in legs became intense; I could not sit on the toilet. Went to emergency room of Hospital at 9pm; no medications given. Pain calmed by 10pm, but sensation in legs returned at 11pm and continued until discharge at 1:15am on 3/6. Took Tylenol PM at home for moderate pain in legs and went to bed. Awakened next morning to no pain, had breakfast and went back to bed until noon. Feeling fine since that time. | ||||||||||||||||
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: Immediately began to feel a headache, dizzy and nauseated. The doctor on site had me lie down on the floor. Was starting to feel better so was able to sit up in a chair for about 15 minutes. Another wave of dizziness and nausea came over and was lying on the floor again. It was hard to breathe, but oxygen and HR were good. The doctor tried to give me juice to see if it was my blood sugar going low, but afterward, I still felt dizzy and nauseated. It was still hard to breathe. It felt like something was sitting on my chest. BP was elevated, oxygen levels were good, HR was good but I started to get a cold chill where my teeth were chattering. At that point (about 45 min to an hour) the symptoms had not gone away and the ambulance was called. Was transported to the local hospital where I received a liter of saline and Zofran for nausea. BP was high, but oxygen levels and HR were good. The heart monitor showed no signs of arrhythmia or tachycardia so I was discharged. The doctor believes it was a side effect and not an allergic reaction. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: After she got the vaccine, she felt dizzy, nauseated and about to faint, her finger was rigid and unable to extend on her left hand (where she got her vaccines on) | ||||||||||||||||
Administered by: Work Purchased by: ?
Life Threatening? No Write-up: Hives breakout all over face and arms - I''ve been taking Benadryl but still present, swelling on eyelids so I could barely open eyes - Been taking benadryl, Fever of 105.3 degrees - Been taking tylenol for 2 days but still have fever, Sore arm and body aches, Overall weakness feeling | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Slight fever began around 4:30pm and I took Tylenol Had chills for about a half hour Around 5pm, I noticed my heart rate was elevated (avg. of 110) and I could feel palpitations while resting Felt well enough to eat dinner at 6pm I kept tracking heart rate and it continued to increase while at rest for prolonged period (120+) When it got into the 130s, went to the ER (around 7:45pm) to check for atrial fibrillation as I was still feeling palpitations Upon arrival, my heart rate was in the 150''s. Was given IV fluids and IV metoprolol tartrate Heart rate came down to 120''s While at the ER, I began to feel much worse Extremely nauseous and had chills Was barely Temperature reached 104.5 (rectal) around 10:00pm Given acetaminophen at 10:19pm Temperature came down Chills went away I was discharged around 12:00am | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Vertigo | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Woke up around 5:30AM having to go to the bathroom. Went to Flush the toilet and passed out on the floor. My wife found me unresponsive but breathing on the floor. My wife called 911 and was at the hospital around 6:15AM. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Fever, chills, nausea, severe headache (still on-going), severe lower back pain (still on-going) | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Patient with previous history of sangioedema reaction to vaccine or medication received J&J COVID single dose vaccine and had throat and chest tightness. Treated by EMS, transported to hospital. The vaccine does not require a second dose. CDC recommendations are that no further action is needed at this time. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Site: Pain at Injection Site-Medium, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Fainting / Unresponsive-Medium | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Systemic: Allergic: Difficulty Breathing-Severe, Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Hyperventilation-Severe | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: PATIENT''S WIFE STATED THAT HE HAD SYMPTOMS SIMILAR TO COVID AND WAS ADMITTED INTO THE HOSPITAL. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: 7 hours post administration, patient had an anaphylactic reaction. she took liquid Benadryl, administered herself an EpiPen, used an albuterol inhaler and went to the er. Patient recovered while in the er and returned home. At pharmacy on the day of the vaccination clinic, patient stayed in a waiting area 15 mins after getting the vaccine. The way our set up was in the store, patient was sitting next to a kiwi plant in the garden and plant area. she is allergic to kiwi. patient is not certain what caused the reaction. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Facial swelling, Diffuse facial rash- 24 hours after vaccine administation Extreme fatigue- immediately following vaccine x2 days Evaluated by PCP and given IM Benadryl and Decadron | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: 10 minutes after injection, dizzy spell and vasovagal reaction. Diaphoretic, pulse rate 48, BP 107/71. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: SOB, Lightheaded Ipratropium Bromide 0.5mg/2.5ml nebs treatment given on site by EMS Patient transported to ER after treatment due to c/o SOB | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Approximately ten minutes following vaccination patient decided to check his blood pressure at the automated machine because he didn''t feel well. Patient passed out sitting at the machine and lost control of his bladder. Patient''s eyes were open and he was making snoring noises. Upon checking pulse, it was faint. Patient was breathing. Team moved patient to lying position on the floor. Pulse became more prominent and patient woke up. EMS arrived and took patient to local hospital for precautionary testing. Patient discharge home 2 hours later. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Patient received the Janssen Vaccine Covid-19 injection and immediately afterwards asked for a trash can. She immediately passed out and fell forward. She hit her head on the wall and received a cut. We called the paramedics and she was transported to the emergency room at the local hospital. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: patient stated she was fine after vaccine, then after a few minutes she stated she felt dizzy. before pharmacist could get back around counter to patient, she fainted and slid out of her chair. patient was alert moments after landing on the floor. patient was laid out on floor and vitals monitored. once vitals returned to normal and patient felt better, she was given water and a banana. EMT arrived and evaluated patient. patient was taken to hospital per EMT suggestion. time frame: 17:26-17:52 | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? Yes Write-up: High Blood Pressure, Jaw Pain !0/10, headache, nausea, involuntary leg movement We are deeply concerned about getting patient the care she needs. There is a lack of urgency on the part of the hospital staff in acknowledging a connection to her receipt of vaccine and onset of adverse symptoms. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: started sore arm soon after, arm pain persisted, heart racing, dry mouth, sore swollen throat, severe headache, spasm in arm | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Symptoms of feeling of doom and injection site itching after vaccine was received. No throat swelling, urticaria, hives, no progression of symptoms. Vital signs WNL -HR-90''s, BP-140/80, 02 Sat-99%. Persistent dizzy and chills. Transported for evaluation to ER. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Medium, Systemic: Hypotension-Mild, Additional Details: Patient fainted 10 minutes after administration of Janssen vaccine. Patient was unconscious for about 15 seconds before regaining consciousness. 911 was called and EMT arrived on scene to monitor''s patients blood pressure and blood sugar. Patient still reported lightheadedness so was taken to hospital by EMT/ambulance. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Mild, Systemic: Nausea-Mild, Systemic: Weakness-Mild, Additional Details: Patient described feeling nauseas about 10- 15 minutes after vaccination then patient fainted. Patient regained alertness a couple minutes after fainting but was still weak and unable to get up. Paramedics came and patient was found to be hypotensive after 15-20 minutes patients blood pressure restored and she was at full alertness and paramedics signed her release. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Post vaccination feeling of breath doom, walking to door to get fresh air. Syncope, fell to floor. No head injury. Post vaccination syncope, brief generalized tonic-clonic movement followed by emesis. Blood glucose 114, BP 120/80, HR90, O2 Sat 96%. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Immediate rash in chest and face. 20 minutes later entered ER with swollen eye and throat. 14 hours later re-entered ER with rash on chest and face, swollen tongue and throat | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: Unknown vaccine information dose given outside of presenting facility. Facial numbness and droop that began after Janssen COVID vaccine. Patient also with panic attack. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: 1515-Vaccine administered-Employee was monitored for 15 min and returned to work. 1600- Employee developed hives, reported to occupational health and benadryl administered. APRN present in Occupational Health. Patient stated he felt that his throat was swelling. Epi-Pen was administered while an ambulance was called, employee was transported to ER. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: FEVER OVER 100, SEVERE HEADACHE, BODY ACHES, CHILLS, RIGORS, SHARP PAINS, CAUSED MY NERVE PAIN FROM THE STROKE TO BE VERY BAD, TINGLING ON MY AFFECTED SIDE, NAUSEA, DIZZINESS, DEHYDRATION, FATIGUE. I WAS GIVEN TYLENOL, IBUPROFEN, ZOFRAN, ATIVAN, AND 2 BAGS OF FLUIDS. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? Yes Write-up: Initially Fever, Fatigue, Joint Pain. 2 days later pain in right abdomen, diagnosed with Appendicitis and had emergency appendectomy performed. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Patient received vaccine at approximately 10:50 AM. She proceeded to the observation area where she began to feel light-headed. On-site EMS from was summoned. EMS placed the woman on their gurney and began assessment (vitals and EKG). A copy of the PCR has been requested, but may not be available. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Difficulty swallowing, severe chills, high fever, and severe joint pain appeared 6 hours after the injection. Was treated with Benadryl, Tylenol, and ibuprofen. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Pt presented with AMS. History provided by father at bedside. For 2 days after vaccine pt reported not knowing what he was doing and where he was. Father brought him to ED after having breakfast together and son didn''t know how to pay or what foods he liked. Was unable to recall his father''s name. Treatment: DAPT with ASA and plavix x21 days and then transition to plavix 75mg daily, atorvastatin 80mg (stroke treatment) Outcome: TBD | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Patient''s entire Left Arm became numb shortly after receiving her vaccination | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: extend amounts of pain in the head, mouth, legs inability to walk | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Patient fainted about 5 minutes after receiving the vaccine. She was in the monitoring area and fell over and hit her head on the ground. I went to her aid and monitored her until the paramedics showed up. She was unconscious for a 10-15 seconds with her eyes open before regaining consciousness. IShe was not having breathing problems or other symptoms of anaphylaxis so i did not administer an epi-pen or benadryl to her. I rolled her on her side in case she became nauseas. Then the paramedics arrived and attended to her. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Patient stated after about 15 minutes after receiving vaccine that her face felt numb, she said it feels like it spread from her arm where the shot was given up into her neck and into her face which was numb and tingly | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Patient fainted after receiving vaccine. Regained consciousness shortly after and began throwing up | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Flu-like symptoms, stabbing chest pain, dizziness, fatigue, rash, and wheezing that developed around 0930 on 3/9. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Patient developed generalized itchiness and nausea 2 minutes after getting vaccine. She has history of food , sulfa, cipro, fluconazole. No rash/hives. Vital signs BP 134/88, Pulse 108, Resp rate 24. EMS was notified and because one team was out transport 911 had to be called. She received epi pen from POD at 1:10AM in Left lateral thigh. VSS. A few minutes later still reported generalized itching and was given Benadryl 50mg PO tablet. FD paramedics on scene and administered IV benadryl, patient became nauseous and dry heaved. She was transported patient to Hospital in the village. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Site: Pain at Injection Site-Mild, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hyperventilation-Medium, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Shakiness-Mild, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Weakness-Mild, Additional Details: Patient alerted me that he was feeling unwell, he started hyperventilating, sweating, shaking, experiencing tingling and numbness throughout his body. Patient was dizziness. He received an epinephrine shot in which he then layed on the floor and started calming down. Paramedics came and checked him out and found him to be alert and well. Patient left store fully recoverd and consulted to go to emergency room if he had any symptoms of an analyphylatic reacction. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Within 30 minutes post vaccine administration, patient started having seizure like symptoms (Altered mental status, clenched jaw, non-verbal, right sided headache) - V/S WNL, Ambulance called and patient was taken to ED for evaluation. Responsive during transport to ED. Patient reported back to baseline after 1.5 hours. | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: received the vaccination at 0900 and has since developed bluing of the fingertips, chills, fever of 101 and tingling of the fingers. She has taken 2 Tylenol for her fever. Advised would recommend eval to HCF for symptoms. They will go to Medical Center. Followed up with caller who adv that they went to the ED. She was evaluated and discharged home. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Patient received J&J vaccine at clinic (lot # 1805022). at approximately 1530, patient has a history of anaphylaxis and was being observed for 30 minutes. Approximately 25 minutes into the observation period the patient was noted to be lethargic, weak, was able to answer questions stated that she felt tingling in throat, numbness, tingling in extremities, back pain. Progressed to feeling itchiness and continued lethargy, was not able to answer what day it was. At that point we assissted patient in wheelchair to get on stretcher behind curtain. Patient given diphenhydramine 50 mg x 1 at 1600, patient became more lethargic and given epinephrine 0.5 mg x 1 at 1603. Vitals after epi were sbp 138, HR ?? reported as elevated, and 02 sats 98. 911 was called. Patient was also nauseous once in wheelchair and on stretcher, wretching when transferred to stretcher patients lower extremities began shaking, lasting a few seconds. Patient motioning towards throat as is if having trouble breathing. Patient remained stable until EMS arrived. I t was reported to me that patient had been cleared by her MD to receive vaccine but to be monitored for 30 minutes. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Systemic: Fainting / Unresponsive-Severe, Additional Details: Patient remembered sitting down in a chair for observation, then slumped forward while on his phone. He did not remember falling over and was alert and oriented right away. Emergency services were called as he sustained an injury during his fall. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: pt became flush and had trouble breathing and fainted | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Patient stated "I am going to pass out." Patient received the Johnson and Johnson vaccine about 10 mintues prior to onset. Patient was located at the recovery station with her son. Patient began to hyperventilate and states she felt like passing out. Patient then went unresponsive and blood pressure was unable to be red. Epi pen was given in right thigh and EMS was called. Patient was transported via EMS to Hospital for evaluation with family members. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Patient was given the Janssen vaccine and within 3 minutes the pt complained that she was lightheaded and dizzy. As I walked out of the pharmacy to see what her reaction was her muscles tensed up and she became completely rigid and stared sliding out of her chair. By appearances it looked like she was shaving a mild seizure, with a blank stare. By the time I got her down on the floor and got her coat off to see if there was an allergic reaction to the site the patient came too and asked me why she was in the floor. At that time she was clamy but knew who she was and where she was. Paramedics were called and while they were here she stated that she was dizzy and nauseous so they ended up taking her to a location hospital to be seen. While there they drew blood as a precaution. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Developed Fever of 105 at 12:30 am - fever finally to 99.7 at 4:00am; chills, body aches, severe lethargy. Sunday 3/7/2021 devleoped knot on arm that has sever burning sensation, hot to touch. Monday 3/8/2021 a fever blister developed on mouth; Tuesday 3/9/2021 - knot still there- Urgent Care visit diagnosed cellulitis - dr stated a puss pocket could be seen under skin and knot on arm size of two quarters. | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: tiredness, breathing heavy, low raspatory rate | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Tightness in throat after 30 minutes, rash across chest. No previous adverse events to vaccinations previously. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Substantial rise in blood pressure to 205/110. This was recorded 20 minutes after injection. The dizziness associated with the high blood pressure started within 5 minutes of the injection. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Received COVID-19 Vaccine on 03/08/2021. About 7:00 am the next morning began having N/V x4 past 12 hrs, diarrhea x 6, headache and blood in urine. Chronic illness of stage 4 kidney disease with bilateral nephrostomy and acute bloody discharge, ulcerative colitis with colostomy and acute high output, CAD with 7 cardiac stents and 2 CABG. A&Ox4, Malaise, tachycardia and hypotension, afebrile. Patient reports chronic abdominal pain unchanged today. Denies back pain, chest pain, cough, or SHOB. Afebrile. Patient has new diagnosis of UTI. IV fluids administered, IV Zofran, Meropenem, and po Hydrocodone/APAP. Transferred due to creatinine of 4.3, bloody urine, and UTI. T: 98.1 HR 91, R-14 BP 106/71, O2 sat 97% | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Patient began feeling unwell and stated that she was experiencing rapid heart rate after receiving vaccine. Paramedics were called and patient was monitored in a seated position while awaiting emergency services. Patient was transported from the pharmacy via emergency services. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: After receiving the vaccine with in minutes the patients left arm began to swell and bruise. He began to become pale and his eyes rolled back into his head and passed out. He woke up a min later and had SOB. Very pale and almost threw up. Paramedics and Firefighters were called. The eveulated the patients and gave him a liter of sodium choride. His Heart Rate was in the 30''s. After several min and a liter of fluid, patient was alert. Once stable he was transported to Hospital. | ||||||||||||||||
Administered by: School Purchased by: ?
Life Threatening? No Write-up: Within seconds of receiving the vaccine I began to feel slightly dizzy. By the time I walked across the room to the observation table I was feeling lightheaded. They sat me down, gave me water and a cookie, but about 2min after the injection the dizziness was so intense that I began to black out. I was unconscious for about 1-2min, then came to but my vision was still unclear. I was taken via wheelchair to the paramedics on the opposite end of the gymnasium, and at this point I was heavily perspiring and very pale but still coherent. I felt my vision and dizziness significantly improve after being able to lay down. I was transported to the hospital for observation but had much improved by the time I arrived. An EKG, bloodwork, and cardiac tests were recommended to discern possible underlying heart related conditions, but I declined because I already had a PAT for thyroid surgery scheduled the next day that would be running those same tests. This reaction was likely due to not having eaten for several hours prior to the vaccine. After about an hour I felt well enough to drive myself back home and dealt with mild aches and pains that evening, chills, and a low grade fever all of which resolved themselves by the next morning. | ||||||||||||||||
Administered by: School Purchased by: ?
Life Threatening? No Write-up: Within seconds of receiving the vaccine I began to feel slightly dizzy. By the time I walked across the room to the observation table I was feeling lightheaded. They sat me down, gave me water and a cookie, but about 2min after the injection the dizziness was so intense that I began to black out. I was unconscious for about 1-2min, then came to but my vision was still unclear. I was taken via wheelchair to the paramedics on the opposite end of the gymnasium, and at this point I was heavily perspiring and very pale but still coherent. I felt my vision and dizziness significantly improve after being able to lay down. I was transported to the hospital for observation but had much improved by the time I arrived. An EKG, bloodwork, and cardiac tests were recommended to discern possible underlying heart related conditions, but I declined because I already had a PAT for thyroid surgery scheduled the next day that would be running those same tests. This reaction was likely due to not having eaten for several hours prior to the vaccine. After about an hour I felt well enough to drive myself back home and dealt with mild aches and pains that evening, chills, and a low grade fever all of which resolved themselves by the next morning. | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: Janssen COVID-19 Vaccine EUA day after had fever that went to 103, extreme fatigue and nausea, oxygen went down to 91 briefly, and heart rate in the 150s while resting. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Nausea-Medium, Systemic: Shakiness-Mild, Systemic: Weakness-Medium, Additional Details: 1:19PM: Pt expressed anxiety, received vaccination, c/o of panic attack and sad down by the chair. 3 secs later, looked flaccid, unresponsive, discolorized, jerked breafly, bladder incontinent, loud sound, no difficulty breathing, no allergic reaction. RPH open airway, layed on side, head raised and called 911. Pt immediated had a deep breath and became responsive, alert/oriented x3. Ambulance, SaO2 97%.Pt later didn''t see the need to urgent care, husband insisted, transported out by ambulance. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Site: Bruising at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Medium, Systemic: Hypotension-Medium, Systemic: Nausea-Mild, Additional Details: Paramedics and Firefighters came out. Gave him 1 liter of normal saline. His heart rate was in the 30''s. They stablizied the patient and took him to hospital. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: On 3/10/2021 at approximately 2035, a female patient notified vaccine observation staff that she was feeling light headed, queasy and anxious. As staff began to assess the patient she began to pass out loosing consciousness. Staff were able to hold patient before any falls and lower her to the floor. The paramedic on scene began her emergency assessment of the patient. Staff paramedic was able to arouse the patient with a sternal rub. The patient was not fully aware of the event that had occurred. The paramedic place the patient on oxygen via nasal cannula. The patient?s level of consciousness began to improve. The patient stated she has a history of syncopal episode after any immunizations. The patient also relayed that she has a history of anxiety and is complaint with her medication. After secondary assessment of the patient, it was noted that the patient had an extended recovery time from the sycopal episode. She was unable to stand on her own and she still felt nauseous after vomiting. The staff at the clinic notified county EMS at 2055 and care of the patient was transferred. | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: Vasovagal syncope a few minutes after vaccination. Fever of 101.8F 24h after vaccination (3/10/2021). Fever is continuing today (3/11/2021), but is lower at 100.4F. Tingling fingers on hand from vaccination arm (left), swelling from vaccination injection site, headache, and neck pain all developed on 3/10/2021. Headache and neck pain could be due to head trauma from vasovagal syncope. Tingling fingers were not observed on 3/11/2021. *I have had vasovagal syncope in the past, but never with vaccines. It always occurs when I see my own blood. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Flushed and sweaty after 20 minutes. Heart started beating fast and irregular. Went by ambulance to ER where given complete smattering of tests, 2 EKG''s Chest xrays, Chest CAT scan, blood work and observation. Heart and BP continued to be elevated during stay. PB 168/85 down to 148/74. Heart rate 110 to 85 ish. Discharged from hospital. Bed at 10:15 feeling ok. During the night fever, chills, swollen glands, nausea, severe body aches, headache. fast heart rate, heavy breathing, general malaise, sleeplessness, painful injection site. Took tylenol at 5:00 AM and slept a few hours. Woke at 10 AM with body aches, but heart rate was down to 76 and BP down to 112/74. Continuing the tylenol and wiped out. | ||||||||||||||||
Administered by: School Purchased by: ?
Life Threatening? No Write-up: sever flu like symptoms. Then chest tightening and inability to breathe. Spouse called 911. | ||||||||||||||||
Administered by: Unknown Purchased by: ?
Life Threatening? No Write-up: Passed out, confused, loopy like they Drunk. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Client contacted NJCRI on 3/11/21 complaining that on 3/10/21 at 10 pm he began feeling tire, achy throat and this morning 3/11/21 at 8 am began with profuse diarrhea, shortness of breath and heart palpitations. BP taken by patient at home 164/90 and pulse of 140 bpm while nurse triaged on the phone. | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Repeated bouts of vertigo | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Patient state she felt light headed and dizziness and "weird". Patient was sitting at the time and I had the patient lay on the ground to prevent any injury in the event she were to pass out. Due to her stating she felt so hot and "bad" 911 was called and dispatched. Upon arrival the patient was seated. and stated she felt weird to the EMS. She stated she did not want to go to the hospital but was unsure if she could stand without passing out. Vaccine was given around 11:40 am and around 11:50 to 11:54am patient started complaining of not feeling well. EMS arrived within 10 minutes of calling 911. Patient stated she did not want to go to the hospital but would go to the ambulance to be evaluated. EMS stated they could exam her in the ambulance and decide from there if she wanted to go to the hospital. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: Per client: As vaccine went in arm went numb, then felt light headed as walking to chair, while sitting vision went blurry and hearing went muffled; feels a little shaky; EMT checked BP 95/66; At 1427 vision and hearing better; BP range 101/68; Client reports her usually BP is "average"; at 1433 BP per EMT 102/72 while sitting; at 1436 BP per EMT while 93/68 standing; client continues to feel lightheaded; EMT discussed treatment options with client to transport her to the free standing emergency department (FSED) or call husband to pick her up. Client decided to call husband to come and pick her up; EMT recommends her to go to FSED. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: patient had chest pain, went to ER, and was found to have heart attack | ||||||||||||||||
Administered by: Other Purchased by: ?
Life Threatening? No Write-up: Heart rate 120 bpm, Blood pressure 170/110, lightheaded, feeling faint, tingling, anxiety | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: Pt was given the vaccine in her left arm. pt went unresponsive and began to have seizure like activity . Pt was in a chair and lowered to the floor with the assistance of the nurse on her right side. 911 was called. 02 at 2L was administered. pt then became responsive. EMTs arrived and transported pt to hospital. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: 61 y.o. right handed male who the Program is consulted for possible stroke. Patient reports that he got his COVID vaccination (Johnson & Johnson) today (3/11/2021) at about 10:30 AM. While waiting after the vaccination, at about 11 AM he became dizzy and felt like he was "loaded" ("stoned from smoking weed") and the started shaking "as though he has a fever but without a fever." and left side sensory loss which is non-disabling. He was taking to a CT scan which was negative for stroke and was discharged home. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: A few seconds after vaccine was given I had a sensation go up my left jawline that felt similar to a nerve pain. I didn''t think much of it and waited the 10 minutes after my vaccine and had no other symptoms. I left the pharmacy and started driving home and had a sudden sensation of a heaviness in my chest and trouble taking a deep breath. I also felt like my tongue and throat were swelling slightly. I had a warm sensation throughout the middle of my back that felt like a heating pad was on it. I felt light-headed and called my husband. As I continued to drive my symptoms worsened and I called 911. I made it home in my car and the ambulance met me there. My husband called the pharmacy to ask them what we should do and they said that it would be ok for him to give me Benadryl. I took 15mL of liquid Benadryl shortly before the ambulance arrived. Within 15-20 minutes, I felt like I was able to swallow better. In the ER, I received IV Benadryl and Famotidine. I was also given 800mg of Ibuprofen for a bad headache I developed. My oxygen level remained in the high 90''s and my symptoms were much improved after the IV medication. I was instructed to continue taking Benadryl capsules for the next few days along with Pepcid to keep my symptoms from flaring back up. I noticed this morning when waking up that the left side of my face as well as my throat felt odd so I took the Pepcid and Benadryl and symptoms were relieved in 30 mins or so. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: Pt fainted and remained dizzy. | ||||||||||||||||
Administered by: Public Purchased by: ?
Life Threatening? No Write-up: THIS PATIENT PRESENTED TO OUR ED AFTER RECEIVING THE J&J COVID-19 VACCINE AT AN OUTSIDE CLINIC. SHE REPORTED RECEIVING THE VACCINE AROUND 1100. AROUND 1200, SHE REPORTS THAT SHE STARTED DEVELOPING HIVES AND FELT LIKE HER THROAT WAS CLOSING. SHE REPORTED TAKING 1 DOSE OF BENADRYL WHICH DID NOT ALLEVIATE SYMPTOMS, SHE REPORTED CALLING HER PCP AROUND 1400 WHO ADVISED HER TO TAKE ANOTHER DOSE OF BENADRYL. SHE REPORTS THAT SHE DID NOT FEEL IMPROVEMENT IN SYMPTOMS SO SHE ARRIVED TO THE ED AROUND 1500. | ||||||||||||||||
Administered by: Private Purchased by: ?
Life Threatening? No Write-up: patient given vaccine and during the 15 minutes wait afterward, patient fainted and hit head on floor. Provider on sit attended to patient and advised patient to go to emergency room. | ||||||||||||||||
Administered by: Pharmacy Purchased by: ?
Life Threatening? No Write-up: After getting vaccinated and escorted to waiting area patient fainted out of chair and hit head on floor. She was briefly unconscious and pale for a few minutes after coming back to consciousness. She remained on the floor feeling dizzy, shaky, and nauseous until she was taken to the hospital by paramedics. | ||||||||||||||||
Link To This Search Result:
https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=SYM&EVENTS=ON&PERPAGE=100&VAX=COVID19&VAXMAN=JANSSEN&ER_ED_VISIT=Yes
Copyright ©
2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166